Archives: InvestorWire

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, announced that research evaluating the company’s gene therapy for type 1 diabetes will be presented at the 16th International Conference on Advanced Technologies & Treatments for Diabetes (“ATTD”). The preclinical data will be presented by GNPX research collaborators at the University of Pittsburg. The conference will be held in Germany on Feb. 22 through 25, 2023. The presentation, which is titled “Pancreatic Intraductal Infusion of Adeno-Associated Virus to Treat Non-Human Primates in a Toxin-Induced Diabetes Model,” will be delivered by Ranjeet Kalsi, DO, who will be representing the laboratory of Dr. George Gittes, MD, a professor of surgery and pediatrics and chief of the Division of Pediatric Surgery at the University of Pittsburgh School of Medicine. The presentation is scheduled for Feb. 25 at 1:45 p.m. Central European Standard Time.

To view the presentation, visit https://ibn.fm/EIf2y

To view the full press release, visit https://ibn.fm/x2zZN

About Genprex Inc. 

Genprex is a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes. Genprex technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes, which currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, nonviral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic, gene-therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is then administered intravenously, where it is then taken up by tumor cells that express proteins that are deficient. The company’s lead product candidate, REQORSA (quaratusugene ozeplasmid), is being evaluated as a treatment for both non-small cell lung cancer (“NSCLC”), with each of its clinical programs receiving a fast track designation from the Food and Drug Administration, and small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 (“Pdx1”) and MafA (“MafA”) genes to the pancreas. In models of type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In type 2 diabetes, where autoimmunity is not at play, it is believed that exhausted beta cells are also rejuvenated and replenished. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF) today announced the publication of a review entitled “Dupuytren’s disease: a localized and accessible human fibrotic disorder” in the journal Trends in Molecular Medicine. In the article, the authors at the University of Oxford, led by Professor Jagdeep Nanchahal, chairman of the medical advisory board of 180 Life Sciences, describe the biology of Dupuytren’s disease, to which their important contributions are recognized by the International Dupuytren Award in 2019, 2020 and 2021. “This review provides an important update on our understanding of molecular basis of Dupuytren’s disease,” said Professor Marc Feldmann FRS, co-chairman of 180 Life Sciences. “By unravelling the signaling pathways and demonstrating their link to the genetics, Professor Nanchahal and his colleagues identified tumor necrosis factor (‘TNF’) as a therapeutic target in the laboratory and went on to demonstrate the efficacy of anti-TNF for the treatment of early-stage Dupuytren’s disease in a phase 2b clinical trial, the results which have been previously announced. Importantly, they have recently shown that anti-TNF treatment could also be cost-effective.”

To view the full press release, visit https://ibn.fm/zE5pu

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs, which are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor).

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at http://ibn.fm/ATNF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent podcast produced by Hacker Valley Studio. The discussion centers around strategy and leadership in cybersecurity, with Haugli sharing what he has learned about a purposeful approach. “Strategy is not technology, it’s figuring out what you want to look like when you grow up, in a sense,” Haugli said, discussing his philosophy and the tenants in creating a strong security strategy. “Everyone jumps to the shiny object. What can I buy to go solve this problem? You never stop and question: Was that the first problem I was supposed to solve? … I think a lot of people throw strategy around as a grander concept and don’t actually think about the elements that need to go into building one. You need to align to a definition that supports your business and outcomes, and that’s what is strategic.”

To view the full article, visit https://ibn.fm/THPDg

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Companies that experience data breaches face, on average, $4.35 million in consequential costs, demonstrating the importance of an effective cybersecurity response
• Small to medium-sized businesses (“SMBs”) generally find the costs of hiring full-time cybersecurity experts to be prohibitive, making it difficult for them to effectively protect themselves from potential cyber crimes
• Virtual chief information security officer (“vCISO”) services are filling the breach with expert cybersecurity consultancy provided on a contract basis that is far more affordable than a full-time hire
• Cybersecurity services and technology provider SideChannel Inc. provides vCISO consultancy as well as proprietary Enclave software that addresses access control needs through microsegmentation
• SideChannel recently reported that its solutions have resulted in 71 percent YOY revenue growth with vCISO-specific services rising 93 percent and recurring software & services growing 367 percent

The industry providing virtual chief information security officer (“vCISO”) services is positioned to grow, given that cybercrime is one of the fastest-growing crimes in the United States and that the average cost of a data breach is $4.35 million, but the cost of hiring a full-time staff CISO can itself run into the hundreds of thousands of dollars, a recent Forbes report notes (https://ibn.fm/1qTwi).

Virtual CISOs provide high-level security service as a consultancy contract without the need for committed staffing, offering a more affordable option. Cybersecurity services and technology provider SideChannel (OTCQB: SDCH) is demonstrating the popularity of vCISO solutions for…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, today announced its participation in the 25th annual Needham Growth Conference. The event is slated to take place from Jan. 10 – 12, 2023, at The Lotte New York Palace in New York City. The company is scheduled to present at 4:30 p.m. ET on Jan. 10, and its management will host one-on-one meetings with investors throughout the conference. Interested parties should visit https://ibn.fm/Qqr0W to register for and access the presentation. In addition, a replay will be available in the Investor Relations section of DoubleDown’s website.

To view the full press release, visit https://ibn.fm/y1jhz

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multi-format interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. Its flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information, visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel’s (OTCQB: SDCH) CEO and Founder Brian Haugli was featured in a recent video interview published by NBC News. The piece discusses an alert issued by the FBI and Homeland Security over cyber attacks targeting the data of teachers, staff and even students as schools come back in session. NBC News’ Tom Winter speaks with stakeholders and experts in the fight against cyber crime as nationwide concerns grow after Los Angeles has seen a trend of these attacks. “These organizations have payroll; they have HR. When I was in the Department of Defense, we used to track some of these groups when they went on holiday and vacations. So, they operate very much like a business,” Haugli said of the threat and the challenge for parents when a child’s digital identity has been stolen. “My kid will inherit this problem and now have to figure this out in ten years. They might go for their first car loan or apply for financial aid and now, suddenly, have all this credit debt…”

To view the full article, visit https://ibn.fm/1sYyL

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PetVivo Holdings (NASDAQ: PETV, PETVW), an emerging biomedical device company focused on the commercialization of innovative medical devices and therapeutics for companion animals, recently announced that it has begun the application process to dual list its shares on Upstream, the revolutionary trading app for digital securities and NFTs powered by Horizon Fintex and MERJ Exchange Limited. According to the announcement, the planned dual listing is designed to provide the company with access to a global, digital-first investor base that can trade using USDC digital currency along with credit, debit, PayPal and USD, unlocking liquidity and enhancing price discovery while globalizing the opportunity to invest in NASDAQ-listed PetVivo. “We are always looking for ways to provide greater liquidity and value to our shareholders,” said PetVivo CEO John Lai. “We see a dual listing on Upstream as being an excellent way to reach a worldwide market of potential new investors who can learn about our company.”

To view the full press release, visit https://ibn.fm/CJ8eS

About PetVivo Holdings Inc.

PetVivo Holdings is an emerging biomedical device company currently focused on the manufacturing, commercialization and licensing of innovative medical devices and therapeutics for companion animals. The company’s strategy is to leverage human therapies for the treatment of companion animals in a capital and time efficient way. A key component of this strategy is the accelerated timeline to revenues for veterinary medical devices, which enter the market much earlier than more stringently regulated pharmaceuticals and biologics. PetVivo has a pipeline of seventeen products for the treatment of animals and people. A portfolio of nineteen patents protects the company’s biomaterials, products, production processes and methods of use. The company’s lead product SPRYNG(TM) with OsteoCushion(TM) technology, a veterinarian-administered, intraarticular injection for the management of lameness and other joint related afflictions, including osteoarthritis, in dogs and horses, is currently available for commercial sale. For more information about PetVivo and its revolutionary product, please contact [email protected] or visit www.PetVivo.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SPYR (OTCQB: SPYR) CEO Tim Matula has released comments regarding the company, which is a diversified technology company developing products leveraging the Internet of Things (IoT) for consumer use and large-scale applications and industries. Matula commented on noteworthy events during 2022 as well as the company’s outlook for 2023. After thanking shareholders, Matula noted that 2022 was “eventful” for SPRY, including the introduction of new management at the beginning of the year as the company evaluated its business and began looking for potential merger acquisitions. That process culminated in June when the company purchased the assets of GeoTraq in a transaction that included the patent and the inventory of more than 13,000 chip sets; SPYR also entered a manufacturing agreement to build the chip sets into finished goods inventory. GeoTraq is a mobile IoT module manufacturer and connectivity provider that offers asset tracking and remote monitoring through mobile IoT modules with global connectivity. “In July we decided began the process of evaluating the performance of our Applied Magix subsidiary,” said SPRY CEO Tim Matula in the press release. “Based on that review, the board of directors concluded that we should focus on our GeoTraq purchase as the market for their products is growing and our belief that with proper funding we would be able to sell the asset tracking devises to a wide range of enterprise customers. On Dec. 12, 2022, we entered into a settlement agreement and release with shareholders resulting in the cancelation and return to treasury of 36,272,684 common shares, representing 10.48% of the issued and outstanding shares of the company as of Dec. 21, 2022. On Dec. 20, 2022, we wound down and dissolved Applied Magix in Nevada, and now we are 100% focused on growing our GeoTraq business, products and services. Our first goal is to complete the over 13,000 chip sets that are ready for assembly. In addition, as we receive further funding our focus will be on expanding our current engineering staff and migrating to 5G chip sets when we order additional chips. We look forward to the new year with enthusiasm as we concentrate all of our efforts on GeoTraq.”

To view the full press release, visit https://ibn.fm/1jt1o

About SPYR Inc.

SPYR Technologies is a technology company focused on the Internet of Things (“IoT”). Through its subsidiary GeoTraq business, SPYR develops and manufactures fully self-contained, ultra-small mobile IoT modules, including Trackertracker-M modules, for asset tracking and location-based services, and Sensorsensor-M modules, used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced that it will showcase a live demonstration of its Mono2Stereo(TM) software-based solution at CES 2023. According to the update, the solution is designed to create 3D perception stereo vision from existing cameras to enhance the performance of existing mono-camera based advanced driver assistance systems (“ADAS”). “The year 2022 saw significant strategic developments for Foresight, as several vehicle manufacturers and tier one automotive suppliers engaged in proof of concept (‘POC’) projects to evaluate the company’s 3D stereoscopic solutions to enhance their existing ADAS systems,” said Haim Siboni, chief executive officer at Foresight. “CES 2023 will give us a chance to showcase our unique technological advances, demonstrating how our software-based solution can benefit the automotive industry.”

To view the full press release, visit https://ibn.fm/jF6R9

About Foresight Autonomous Holdings Ltd.

Foresight is a technology company developing smart multi-spectral vision software solutions and cellular-based applications. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd., Foresight Changzhou Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of-sight” vision systems and “beyond-line-of-sight” accident-prevention solutions. Foresight’s vision solutions include modules of automatic calibration and dense three-dimensional (“3D”) point cloud that can be applied to different markets such as automotive, defense, autonomous vehicles and heavy industrial equipment. Eye-Net Mobile’s cellular-based solution suite provides real-time pre-collision alerts to enhance road safety and situational awareness for all road users in the urban mobility environment by incorporating cutting-edge AI technology and advanced analytics. For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com.

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, today announced that a large Northeast U.S. supermarket chain selected Dario to help improve the cardiometabolic health of its employees beginning in the first quarter of 2023. This marks 100 enterprise contracts signed for DarioHealth and validates its strategic position as a leading provider of integrated digital chronic condition management solutions in the employer and payer markets. “Throughout 2022 we saw that the demand for our integrated multi-condition solutions grow at a steady pace, and the addition of this employer marks a tremendous achievement for Dario. Hitting our goal of 100 contracts by the end of 2022 is a testament to the vision we set forth over a year ago,” said Rick Anderson, president of Dario. “The fact that most of the contracts signed in 2022 and more than 50% of our pipeline are for multiple conditions represents market validation of our multi-condition suite approach. There is a clear trend with enterprise customers seeking multiple conditions from less vendors. Given our multi-condition suite strategy we believe that we are well positioned for growth in the future market.”

To view the full press release, visit https://ibn.fm/LL1wd

About DarioHealth Corp.

DarioHealth is a leading digital therapeutics (“DTx”) company revolutionizing how people with chronic conditions manage their health through a user-centric multi-chronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to health care. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention and results. Making the right thing to do the easy thing to do. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. To learn more about DarioHealth and its digital health solutions, or for more information, visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) is a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs. The company today announced its entry into a letter of intent with Massachusetts General Hospital (“MGH”), the largest teaching hospital of Harvard Medical School, to fund and conduct a phase 2a clinical trial investigating the effects of psilocybin-assisted psychotherapy in the treatment of patients aged 21+ suffering from irritable bowel syndrome (“IBS”). “MGH is an ideal partner for Tryp to expand on its strategy of utilizing TRP-8802 (oral psilocybin) to explore the clinical potential of psilocybin-assisted psychotherapy in new indications,” said Jim Gilligan, PhD, chief executive officer of Tryp Therapeutics. “With positive results in this study, Tryp would look to continue clinical development in IBS with TRP-8803, our proprietary formulation of IV-infused psilocin, that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. Our ultimate goal is providing even more favorable outcomes and relief to the millions of patients currently suffering from IBS and its associated disorders. With this agreement in place, we will be in a position to submit the relevant IND.”

To view the full press release, visit https://ibn.fm/7cfby

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

BlockQuarry (OTC: BLQC), a Texas-based company with commercial-stage operations in cryptocurrency mine hosting and self-mining in the southeast United States, is reporting on its unaudited financial highlights for the three and nine months ended Sept. 30, 2022. Financial highlights of the report show total revenues for the three-month period s of $2.098 million with total revenue for the nine-month period of $4.46 million. The company’s total assets were $10.42 million with current liabilities of $16.4 million. Operational highlights for the period include partnering with a consultant to provide services to support the company’s efforts to uplist to a higher exchange as well as an agreement with Bitmain to amend an existing service framework agreement to increase hosting service fees from $0.05275 per kilowatt hour to $0.07 per kilowatt hour. In addition, the company announced that a board of directors charter has been submitted to the state of Nevada and that it has filed an amended S1 registration statement with the updated Q3 financial reports. The company also significantly reduced its convertible debt with legacy note holders. “I am extremely proud of our third-quarter financial performance, despite very difficult current overall market and cryptocurrency market conditions,” said BlockQuarry president and chair Alonzo Pierce in the press release. “We were able to book a phenomenal quarter that featured continued strong topline growth, and we made substantial headway on key corporate objectives. . . . We were successful in hitting a number of key objectives in Q3, including a necessary reworking of our agreement with Bitmain to protect the company and ensure we are covered during peak power months. We were also able to get our board of directors and advisors finalized as well as hire a consulting firm to help us with the uplisting process.”

To view the full press release, visit https://ibn.fm/CMx2Z

About BlockQuarry Corp.

BlockQuarry focuses on cryptocurrency mine hosting and self-mining operations at a leased property located in Gaffney, South Carolina. BlockQuarry also maintains a fleet of digital/cryptocurrency mining equipment and infrastructure. For more information about the company, visit www.BlockQuarry.io.

NOTE TO INVESTORS: The latest news and updates relating to BLQC are available in the company’s newsroom at http://ibn.fm/BLQC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sustainable Green Team (OTC: SGTM), an industry-leading wholesale manufacturer and supplier of consumer and industrial wood-based mulch, soil, and lumber products nationwide, announced that CEO Anthony J. Raynor was slated to present at the Global Unity Foundation’s Summit pitch competition; the competition was held Dec. 31, 2022. During his presentation, Mr. Raynor provided an overview of the company’s achievements and highlights for the past year; the presentation also included a review of SGTM’s upcoming opportunities and goals as well as the company’s vision for growth. According to the announcement, the mission of Global Unity Foundation (“GUF”) is to unite the world through humanitarian efforts by working with community leaders, influential individuals and socially conscience organizations to eradicate poverty, advance health and wellness, create economic sustainability and promote universal quality education. “I am excited to share our vision, passion, and plan to positively change our world at the Global Unity Summit and Gala,” said Sustainable Green Team CEO Anthony J. Raynor in the press release. “I believe that there is no greater way to end 2022 than presenting and networking in such a prestigious event as we enter the new year.”

To view the full press release, visit https://ibn.fm/pxs1C

About Sustainable Green Team Ltd.

The Sustainable Green Team is a wholesale manufacturer and supplier of wood-based mulch, soil and lumber products, selling directly to mass merchandisers, home centers, hardware stores, nurseries, garden centers, convenience stores and food stores, in addition to wholesalers and distributors. The company also provides arbor care and storm-recovery services at the residential, commercial and municipal levels while offering green-waste solutions to large- and small-scale waste disposal and recycling companies located throughout the southeastern United States. The company’s subsidiary, Mulch Manufacturing Inc., is the largest provider of cypress mulch in the country. SGTM has entered into an agreement with Australia-based VRM Biologik Group to bring VRM’s world-leading, soil-moisture technology to the Unites States at scale. HumiSoil(R) and XLR8 Bio(R) are soil-treatment products that rebuild soil hydration on a cellular level, improving the soil and the vegetation and agricultural products it supports. The company will make HumiSoil and XLR8 Bio available for home gardens and lawns throughout the United States to help relieve water use in cities as well as to help VRM Biologik Group in its mission to restore productivity in depleted topsoil in 25% of the world’s arable land. For more information about the company, please visit www.TheSustainableGreenTeam.com.

NOTE TO INVESTORS: The latest news and updates relating to SGTM are available in the company’s newsroom at http://ibn.fm/SGTM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Silo Pharma (NASDAQ: SILO), a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research, is reporting positive interim data from its dose optimization study of SPU-21 joint homing peptides for subcutaneous administration of anti-arthritic agents. According to the announcement, SPU-21 is effective in controlling arthritis progression and exhibits positive data in arthritis suppression. The company noted that it is following a development plan utilizing its liposomal joint homing peptides as a potential therapy for rheumatoid arthritis (“RA”). The study is designed to evaluate the disease-suppressive effects of an SPU-21 peptide-guided anti-arthritis drug compared to the drug alone. SILO is working with the University of Maryland, Baltimore to develop the SPU-21 liposomal joint homing peptides. “We believe that the positive results of these latest tests show that our peptide with DEX given subcutaneously was effective in controlling arthritis progression,” said Silo Pharma CEO Eric Weisblum in the press release. “The effect of lipo-DEX was superior to that of DEX alone when both were administered via the SC route. Since patients widely prefer SC administration over intravenous (‘IV’) infusion for multiple reasons, we believe the superiority and practicality of our liposomal joint homing peptide bode well for broad market potential. Meanwhile, we continue to explore other novel therapeutics for optimal pairing with SPU-21, targeting rheumatoid arthritis as our initial indication.”

To view the full press release, visit https://ibn.fm/X9YF3

About Silo Pharma Inc.

Silo Pharma is a developmental-stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research indications such as Alzheimer’s disease, PTSD and other rare neurological disorders. Silo’s mission is to identify assets to license and fund the research that the company believes will be transformative to the well-being of patients and the health-care industry. For more information about the company, visit www.SiloPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to SILO are available in the company’s newsroom at https://ibn.fm/SILO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• CubCrafters recently announced that the US Department of Agriculture Wildlife Service had selected its flagship FAA-certified CC19 XCub for a new government aircraft-fleet-modernization contract
• The contract extends a long-term working relationship that has seen CubCrafters supply aircraft to various federal agencies since 2003
• CubCrafters aircraft have a lower operational cost than helicopters in addition to being reliable and safe with much of the same capability
• According to CubCrafters, the aircraft fleet modernization contract is important not only to the company as a supplier but also to investors participating in its ongoing public offering, which was recently qualified by the SEC

For close to two decades now, CubCrafters, a Yakima, Washington-based designer and manufacturer of Part 23 Certified, Experimental, and Light-Sport backcountry aircraft, has supplied aircraft to various US Federal Government agencies, including the US Air Force Research Laboratory, the US Air Force Flight Academy, the US Department of Agriculture (“USDA”), the US Department of Homeland Security (“DHS”), and the US Department of the Interior (“DOI”).

“Our long relationship with the US Government is a strong testament to our ability to design and manufacture exceptionally rugged utility aircraft for backcountry missions,” says CubCrafters President and CEO Patrick Horgan of the relationship that began in…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Blue Hat Interactive (NASDAQ: BHAT), a leading communication services and internet data center (“IDC”) business provider, producer and developer, as well as an operator of mobile games and augmented reality (“AR”) education curricula and products in China, is reporting unaudited financial results. The results are for the second quarter 2022, or the three months ended June 30, 2022, and the first half of 2022, or the six months ended June 30, 2022. Highlights of the report include Q2 2022 total revenues of $1.7 million, gross profit of $1 million, loss from operations of $3.3 million and net loss from continuing operations of $3.4 million. First half 2022 numbers reached total revenues of $2 million, gross profit of $1.2 million, loss from operations of $6 million and net loss from continuing operations of $6.2 million. The company also reported $3 million in cash and cash equivalents as of June 30, 2022. The report noted that the global COVID-19 pandemic has negatively impacted the company’s financial performance. “In order to cope with the current situation of the economy environment, some adjustments have been made to the company’s business, and the company has suspended or reduced the AR Immersive Course (“ARIC”), game and communication business, which were severely affected by the COVID-19 pandemic,” said Blue Hat Interactive CEO Xiaodong Chen in the press release. “The company has increased the commodity supply chain commodity trading platform project and increased the breadth of the company’s business. At the same time, the company has increased the investment and development of some new projects such as new energy graphene, which will provide some foundation for the future development of the company, to grow the company steadily and maximize shareholder value.”

To view the full press release, visit https://ibn.fm/wVll2

About Blue Hat Interactive Entertainment Technology

Blue Hat is a leading communication services and IDC business provider as well as a producer, developer and operator of AR interactive entertainment games, toys and educational materials in China. Distinguished by its own proprietary technology, Blue Hat aims to create an engaging, interactive and immersive community for its users.

NOTE TO INVESTORS: The latest news and updates relating to BHAT are available in the company’s newsroom at http://ibn.fm/BHAT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, has filed its interim financial statements for the six-month period ended Sept. 30, 2022. The company has also filed associated management’s discussion along with analysis and related officer certifications for the same period. Highlights of the report include gross revenue for the company totaling $8,869,579 and cost of goods sold reaching $5,542,113. Net loss for the six-month period was $8,964,219. The company also stated that, as it has filed the interim filings, together with the filing of its audited annual financial statements for the year ended March 31, 2022, as well as associated management discussion and analysis and related officer certifications, it anticipates applying to the British Columbia Securities Commission for full revocation of the “failure to file” cease trade order (“CTO”) issued by the commission in October 2022. “Trading is expected to resume on the Canadian Securities Exchange shortly after the revocation of the CTO,” the company said in the announcement. “The company is now current with all regulatory financial statement filings.”

To view the full press release, visit https://ibn.fm/zexPo

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX is the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor-plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. However, the business is not limited to an e-commerce platform. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

VistaGen Therapeutics (NASDAQ: VTGN), a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders, has recently filed national applications at the U.S. Patent and Trademark Office designed to provide additional patent protection for its lead product candidate, PH94B. The company has also filed similar applications with counterpart patent authorities in major pharmaceutical markets outside the United States. The filings are related to PH94B and the treatment of adjustment disorder (“AjD”). According to the company, these filings are a strategic “next step” in VistaGen’s ongoing efforts to enhance potential commercial protection across its CNS pipeline in key pharmaceutical marketsand provide global exclusivity platform for PH94B in AjD; the company is working to provide patent protection that is similar to that of its protection for PH94B for the treatment of social anxiety disorder (“SAD”) as well as its exclusive late-clinical stage product candidate, PH10, for the treatment of major depressive disorder (“MDD”). The company also noted that it is in the process of finalizing an acquisition of its acquisition of Pherin Pharmaceuticals Inc., which will include Pherin’s entire pherine pipeline as well as intellectual property rights to PH94B, a substance that is in phase 3 development for the treatment of SAD and phase 2 development for the treatment of AjD with anxiety (“AjDA”), and PH10, which is in clinical development for MDD. The acquisition will also give VistaGen full ownership of three new early clinical-stage pherine product candidates: PH15 for cognition improvement, PH284 for appetite-related disorders, and PH80 for migraine and hot flashes.

To view the full press release, visit https://ibn.fm/OVJEk

About VistaGen Therapeutics Inc.

VistaGen is a late clinical-stage CNS-focused biopharmaceutical aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster acting and with fewer side effects and safety concerns than those that are currently available. VistaGen’s clinical-stage candidates are targeting multiple types of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are odorless and tasteless investigational neuroactive steroids designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. VistaGen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression — one mind at a time. For more information about the company, please visit www.VistaGen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has released a letter to shareholders; the letter is signed by CEO James Woody. In the letter, Woody notes that the company’s priority continues to be its clinical programs, repurposing anti-tumor necrosis factor (“TNF”) drugs for the treatment of Dupuytren’s disease, frozen shoulder and post-operative delirium. Woody reports that results from the company’s phase 2B trial exceeded expectations and showed that the treatment will most likely be cost effective. In the letter, Woody stated that, after obtaining scientific advice from the UK Medicines and Healthcare products Regulatory Agency (“MHRA”) and after discussions with regulatory consultants in the United States and United Kingdom, the company is preparing the material required to seek marketing authorization in the UK; the company plans on filing the application in mid-2023. “Enrollment to the trial of anti-TNF for early-stage frozen shoulder is slower than anticipated in the UK as patients typically present to physical therapists and the processes are subject to delays,” stated 180 Life Sciences CEO James Woody in the shareholder letter. “In the USA, all such patients are seen by orthopedic physicians, who are relatively easy to access. The trial team has implemented several strategies to improve recruitment, and we hope that these will be effective. Preparation for the trial of anti-TNF to prevent the development of postoperative delirium remains on track, and we anticipate that the first patient will be recruited in the first half of 2023. Our focus remains on our clinical portfolio. . . and we plan to continue to evaluate the timing and cost/benefit of additional ongoing research for our early discovery programs.”

To view the full shareholder letter, visit https://ibn.fm/ZkCj1

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain by leveraging the combined expertise of luminaries in therapeutics from Oxford University, the Hebrew University and Stanford University. 180 Life Sciences is leading the research into solving one of the world’s biggest drivers of disease: inflammation. The company is driving groundbreaking studies into clinical programs, which are seeking to develop novel drugs addressing separate areas of inflammation for which there are no effective therapies. The company’s primary platform is a novel program to treat fibrosis using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was one of several cybersecurity experts quoted in a recent PEW article reporting on the fact that at least 18 state governors have banned the use of the social media app TikTok on government devices. The article, titled “Governors’ TikTok Bans Make Sense, Cybersecurity Experts Say,” note that the state leaders are concerned about potential security risks because the app is owned by a Chinese company and may be used to collect data from users’ devices. The article contains quotes from numerous cybersecurity experts in support of the action, which could be viewed as political; all the states making the decision were led by Republican governors. Some governors took further action, banning other Chinese-owned apps and products such as WeChat, QQWallet and AliPay. Haugli was also quoted in an online article published by The Information titled “TikTok Owner Now Aiming to Expand into U.S. Enterprise Software Market.” In addition, the PEW article noted that bipartisan action had been taken on the federal level, with the U.S. Senate unanimously passing a bill that would prohibit federal employees from using TikTok on government-owned devices. “TikTok can access your camera and phone, the Wi-Fi connection, contacts, GPS, storage. It can read what you are doing and the things you’ve done,” said SideChannel CEO Brian Haugli in the article. “That thing can tell you where your eyeballs are looking.”

To view the full articles, visit https://ibn.fm/DAw0r and https://ibn.fm/gtFUC

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Standard Lithium (TSX.V: SLI) (NYSE American: SLI) (FRA: S5L), a leading near-commercial lithium company, today announced that the United States Patent and Trademark Office (“USPTO”) has issued a Notice of Allowance for Standard Lithium’s third U.S. patent application. The application, serial no. 16/895,783, titled “Process for Recovering Lithium from Brines,” is in addition to Standard Lithium’s other two U.S. patent applications for which Notices of Allowance have been earlier issued by the USPTO. The three applications comprise a portion of Standard Lithium’s novel and proprietary technique for continuous Direct Lithium Extraction (“DLE”) from lithium brines. “We are pleased to have received the Notice of Allowance for the final U.S. patent application of the company’s lithium extraction technology,” said Dr. Andy Robinson, Standard Lithium’s president and COO. “We will continue to strengthen our IP portfolio, but, more importantly, we are actively advancing our south Arkansas lithium projects and doing so by applying sustainable, scalable and fully-integrated modern processing technologies to unlock new U.S. commercial lithium production.”

To view the full press release, visit https://ibn.fm/zQWn9

About Standard Lithium Ltd.

Standard Lithium is a leading near-commercial lithium development company with a portfolio of projects in process. The company’s flagship projects, the LANXESS Property and the South West Arkansas Project, are located in southern Arkansas near the Louisiana state line. The company is focused on the evaluation and testing of commercial lithium extraction and purification from brine sourced from approximately 180,000 acres of unitized leases across these two projects. The company operates a first-of-a-kind industrial-scale Direct Lithium Extraction (“DLE”) Demonstration Plant at the LANXESS Property Project. The scalable, environmentally friendly process eliminates the use of evaporation ponds, reduces processing time from months to hours and greatly increases the effective recovery of lithium. A Definitive Feasibility Study (“DFS”) and Front-End Engineering Study (“FEED”) for Phase 1A of the LANXESS Property Project commenced in September 2022. A Preliminary Feasibility Study (“PFS”) of the South West Arkansas Project commenced in May 2022. The company is also pursuing the resource development of approximately 45,000 acres of mineral leases located in the Mojave Desert in San Bernardino County, California. Standard Lithium is jointly listed on the TSX Venture Exchange and the NYSE American under the trading symbol SLI and on the Frankfurt Stock Exchange under the symbol S5L. For more information, please visit the company’s website at www.StandardLithium.com.

NOTE TO INVESTORS: The latest news and updates relating to SLI are available in the company’s newsroom at https://ibn.fm/SLI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SideChannel is a company focused on making cybersecurity simple and accessible based on the belief that all companies, including small and mid-sized businesses, deserve top-tier security guidance
• Currently, companies are facing the potential of stiffer economic times, demanding more cost-effective solutions to maintain and grow operations
• In these uncertain times, SideChannel offers a significant cost advantage as it provides top-tier security guidance at a manageable cost

In response to tighter budgets, companies have been focused on reducing expenses, streamlining operations, managing cash flows, and building cash reserves, among other interventions. At the same time, companies are recognizing the growing importance of cybersecurity. A November 2022 Global Tech Investment Predictions Report published by IBM and Morning Consult ranks cybersecurity solutions as the second top technology companies plan to invest in over the next two years, after 5G. The report further lists cyber risks as the leading factor driving investments in technology in organizations (https://ibn.fm/sMTnN). Furthermore, separate predictions expect the rising cybersecurity threats and risks to continue into 2023 and beyond (https://ibn.fm/nvHfO), crystallizing the decision by companies to pursue the above investments.

The need to control costs is forcing companies to prioritize less expensive services over costlier products (https://ibn.fm/P61Hn). Coupled with the growing demand for cybersecurity, companies are aggressively seeking the most cost-effective solutions to keep their operations safe. The situation works to the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• CubCrafters is a producer of best-in-class backcountry aircraft made under the light sport, experimental, and FAA-certified (Part 23 certified) aircraft categories
• In 2022, the company achieved several milestones, including filing and receiving qualification for a public offering under the Regulation A+ exemption, marking the first time the company has opened to outside investment in its 42-year history
• The company aims to raise $50 million, channeling the proceeds from the offering toward accelerating manufacturing, enhancing manufacturing capabilities, furthering innovation, and improving customer service
• CubCrafters also released a new, improved engine for its Experimental aircraft
• In addition, CubCrafters announced its flagship XCub aircraft had been selected by the United States Department of Agriculture (“USDA”) for a new government aircraft-fleet-modernization contract

Though not new, backcountry aviation has exploded in the past 25 years, according to an article in the Plane&Pilot Magazine, driven in part by pilots’ need to fly their own aircraft for the rewards of the experience and adventure (https://ibn.fm/Zguzn). This growth has pushed demand for backcountry aircraft capable of taking off and landing on varied rough terrain or water, let alone well-groomed and paved runways.

For a backcountry aircraft manufacturer whose history spans more than 40 years, CubCrafters has witnessed firsthand the explosion of the industry. And to quench aviation enthusiasts’ ever-growing desire for backcountry and light aircraft, the Yakima, Washington-based company has been growing…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters Inc. are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

DoubleDown Interactive (NASDAQ: DDI), a leading gaming company delivering unique player experiences across a variety of genres, is reporting on its extraordinary general meeting of shareholders, which was held on Dec. 28, 2022 (Korea Standard Time) or Dec. 27, 2022 (U.S. Eastern Time). The meeting was held in Seoul. During the meeting, shareholders of record approved the reduction of the company’s capital reserve in the amount of KRW 330 billion; the reduction was proposed by the company’s board of directors.

To view the full press release, visit https://ibn.fm/Fgn6a

About DoubleDown Interactive Co. Ltd.

DoubleDown Interactive is a leading developer and publisher of digital games on mobile and web-based platforms. The company is the creator of multiformat interactive entertainment experiences for casual players, bringing authentic Vegas entertainment to players around the world through an online social casino experience. DDI’s flagship title, DoubleDown Casino, has been a fan-favorite game on leading social and mobile platforms for years, entertaining millions of players worldwide with a lineup of classic and modern games. For more information about this company, please visit www.DoubleDownInteractive.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by the Worcester Business Journal (“WBJ”). The piece highlights SideChannel’s 71% year-over-year revenue increase in fiscal 2022, in its first report since combining with Austin encryption company Cipherloc Corp. “Cipherloc announced the acquisition of SideChannel on July 5, saying the combined company would take the name of the Worcester firm. In a Tuesday press release, the company called the merger a business combination and determined that SideChannel was the acquiring entity for accounting purposes,” the article reads. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” SideChannel CEO Brian Haugli was quoted as saying. “Our investments in sales and marketing, coupled with our expanding cybersecurity, privacy and risk management capabilities, has proven to be effective at acquiring new clients and retaining existing relationships.”

To view the full article, visit https://ibn.fm/7NPoP

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced its board of directors has approved a share repurchase program. Under the program, the company may purchase its own ADSs with an aggregate value of up to US$5 million from Jan. 1 to Dec. 31, 2023. The company intends to fund the repurchase from its existing cash balance, including cash generated from its operations. iClick expects to effect the proposed share repurchase on the open market at prevailing market prices, in negotiated transactions off the market and/or in other legally permissible means as conditions warrant in compliance with applicable requirements of Rule 10b5-1 and/or Rule 10b-18 under the U.S. Securities Exchange Act of 1934, as amended, at times and in such amounts as the company deems appropriate.

To view the full press release, visit https://ibn.fm/T09M8

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CubCrafters was featured in a recent article published by AVweb, the world’s premier independent aviation news resource. The piece, written by Mark Phelps, delves into CubCrafters’ recent strategic acquisition. “Just in time for ski season, backcountry aircraft icon CubCrafters is showing its fiscal savvy by acquiring Summit Aircraft Skis. The manufacturer of Part 23-certified, light-sport and experimental aircraft bought the design and manufacturing assets, unique patents and related intellectual property of Sandpoint, Idaho-based Summit Aircraft Skis, which are ‘favored by [CubCrafters’] Carbon Cub aircraft owners and preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft,’ according to the CubCrafters press release,” the article reads. Brad Damm, CubCrafters’ vice president, is quoted as saying, “Summit Skis, when combined with the outstanding wintertime defrost and cabin heater technology used on our FX-3 model, makes that aircraft the ultimate ski airplane.”

To view the full article, visit https://ibn.fm/ubEK6

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by TechDecisions. The piece highlights SideChannel’s launch of the Enclave microsegmentation platform, which offers small to mid-sized businesses (“SMBs”) a solution to simplify and maintain a segmented network with minimal IT administration and maintenance. Enclave is designed to enable IT personnel to easily segment their company’s network, quickly organize individuals and machines to each individual’s workload level, then implement security controls across all segments. “Small and mid-market companies are incredibly challenged by a lack of cost-effective means to comfortably and securely handle network management,” one of the lead developers behind Enclave, SideChannel’s executive vice president David Chasteen is quoted as saying. “These companies want to focus on their business and their customers; not worry about who is accessing what server, or if the encryption installed is sufficient. We built Enclave to provide these companies an affordable and effective segmentation solution that significantly reduces the amount of effort required, through a simple and intuitive interface.”

To view the full article, visit https://ibn.fm/iN02B

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, has filed its restated audited consolidated comparative financial statements and accompanying management’s discussion and analysis for the year ended March 31, 2021. The company also filed its annual financial statements for the year ended March 31, 2022, along with its associated management’s discussion and analysis and related officer certifications. The company also noted that it is in the process of completing its interim financial statements, associated management’s discussion and analysis and related officer certifications for the three-month period ended June 30, 2022; it is also working to file its interim financial statements, associated management’s discussion and analysis and related officer certifications for the six-month period ended Sept. 30, 2022.

To view the full press release, visit https://ibn.fm/l26mH

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX is the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans to expand its product lines to include cosmetics, clothing and its own water brand. However, the business is not limited to an e-commerce platform. PlantX uses its digital platform to build a community of like-minded consumers and, most importantly, to provide education. Its successful enterprise is being built and fortified on partnerships with the top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, is sharing projections for its Q4 2022 revenue. According to the announcement, the company anticipates revenue for the last quarter of 2022 to “exceed quarterly revenue for any quarter over the past four years, and may achieve the highest quarterly revenue ever for the company.” PBIO attributed the growth to foundations built and momentum achieved earlier in 2022, which was driven by the commercial release of the company’s revolutionary Ultra Shear Technology(TM), or UST(TM) platform. “Our development of UltraShear over the past six years presented a pivotal, game-changing nanoemulsions technology that we believe will restate the basis of competition for a myriad of products across multiple major industries,” said Pressure BioSciences president and CEO Richard T. Schumacher in the press release. “We have assembled a strong and differentiated IP position and unique engineering and scientific expertise to unleash this opportunity, for PBI and for clients worldwide. We made the critical decision in early 2022 to pivot our business focus and resources almost entirely onto accelerating the UltraShear platform, building commercial-stage UST processing equipment, creating pivotal technology demonstrations with select partners in multiple industries, and accelerating our path to commercial traction and a revenue growth inflection. . . . Astonishing early demonstrations of UltraShear’s unique differentiation of products continue to mount up, and more partners and early marketing results are gathering already for revenue acceleration in Q1 and throughout all of 2023. We are grateful daily for the patient support of our many long-term investors, and we are excited to have them at our side as PBI enters an exciting new era of revenue growth, profitability, and a planned uplist to a national exchange in 2023.”

To view the full press release, visit https://ibn.fm/07VHI

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has closed on its previously announced registered direct offering. The offering, which was with a single healthcare-focused U.S. institutional investor, was comprised of 1,714,286 shares of the company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,571,429 shares of common stock. The units were priced at $3.50 per share and accompanying warrant. According to the announcement, the warrants have an exercise price of $3.50 per share and are initially exercisable beginning six months following the date of issuance; they also expire five years from the initial exercise date. Gross proceeds from the offering total an estimated $6 million, which the company anticipated using for R&D expenses as well as general corporate purposes.

To view the full press release, visit https://ibn.fm/6Zcaj

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, has announced its subsidiary HearingAssist, America’s No. 1 affordable OTC hearing aid brand, has launched its FDA-registered OTC rechargeable hearing aids on CVS.com. HearingAssist OTC hearing aids also launched in eight selected CVS pharmacy locations in Massachusetts and Rhode Island. “This latest launch of HearingAssist OTC rechargeable hearing aids with CVS and on CVS.com is a result of our continuing efforts to execute our wholesale distribution plan,” said Matthew Moore, president and CEO of InnerScope. “Having both InnerScope’s Hearing Assist and iHEAR OTC hearing aid brands listed on CVS.com and HearingAssist Rechargeable OTC hearing aids in eight selected CVS pharmacies expands InnerScope’s category presence within CVS’s OTC hearing aid market segment. We believe that when customers compare all the features of HearingAssist and iHEAR OTC hearing aids deliver against the cost and features of the other competitors, we will come out ahead.”

To view the full press release, visit https://ibn.fm/WahTi

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com , HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite / SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Sharing Services (OTCQB: SHRG) is dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies. The company recently introduced the traveling world to a whole new approach to savings as well as a unique opportunity for those looking for additional income in the gig economy through the inaugural event for Hapi Travel Destinations. “A wholly owned subsidiary of Sharing Services, Hapi Travel Destinations is a global leader in fun-filled, one-of-a-kind travel and offers exclusive travel-club membership… Sharing Services unveiled Hapi Travel Destinations in September, noting that the unique membership-based travel club was specifically designed for travelers to enjoy maximum savings and travel perks on the most luxurious vacation getaways throughout the world while also saving money on ordinary daily personal or corporate travel,” a recent article reads. “Our timing could not be better,” Hapi Travel VP Dave Dove is quoted as saying. “After two years of social distancing and limited travel, people are ready to get out and experience new locations and revisit the places they love. Unfortunately, the rising costs of travel now make this difficult for the average family. Our unique memberships are tailor-made to give access to deep savings for weekend getaways, resort vacations, business travel, flights and hotels. We back this program with a 110% guarantee.”

To view the full article, visit https://ibn.fm/HudLe

About Sharing Services Global Corporation

Sharing Services is a publicly traded company dedicated to maximizing shareholder value through the acquisition and development of innovative companies, products and technologies in the direct-selling sector and other industries. Sharing Services’ combined platform currently leverages the capabilities and expertise of various companies that market and sell products direct to the consumer through independent contractors. For more information, visit www.SHRGInc.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, has announced that it is “adding contracts with self-insured employers and national health plans as Amazon and CVS vie to lead value-based, patient-centric virtual healthcare.” According to the announcement, digital healthcare is delivering both better health outcome and also lower costs for the national health-care sector. Dario’s proprietary offering features a user-centric, multichronic condition platform and suite of solutions designed to deliver personalized and dynamic interventions based on data analytics; the platform also includes one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain and behavioral health. The platform provides a turnkey, one-vendor solution for payers, observed DarioHealth. The company has consistently announced new contracts, most recently signing an agreement with a “jumbo” global employer account that represents the increasing penetration of the Dario platform. The announcement also noted that DRIO is delivering on its goal to sign 100 enterprise contracts by the end of year; the company is also reporting a strong balance sheet with $68 million in cash and equivalents as of June 30, 2022, and an additional $25 million of availability on an existing credit facility. DarioHealth is “well positioned and capitalized, signing significant contracts with large clients,” the company stated in the announcement. “The digital therapeutics market is being forced to consolidate with pressure from consumers to deliver healthcare on a value-based system. With Dario’s clinically verified ROI to payers lowering costs for the national healthcare sector, DRIO is clearly delivering in a high-demand market. Investors looking to capitalize on the digital health sector need to put DRIO on their radar.”

To view the full press release, visit https://ibn.fm/Iq2Sh

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

McEwen Mining (NYSE: MUX) (TSX: MUX), a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina, is reporting on its October and November production as well as forecasting numbers for the remainder of the year; the company also released its guidance for 2023. According to the announcement, total production for October and November reached an estimated 26,700 gold equivalent ounces (“GEO”) with preliminary costs per ounce from McEwen’s 100%-owned operations of $826 for cash costs and $1,088 for all-in sustaining. The report noted that at San José Mine, costs per ounce for October and November were $1,361 for cash costs and $1,745 for all-in sustaining. The report also noted that consolidated production guidance for 2023 represents an 11% to 25% increase from 2022 forecast production. The bottom line? Production is increasing and costs per ounce are falling, the company stated. “As we end 2022, we would like to give our shareholders an update on our recent production results and costs, which illustrate the turnaround we are executing as well as our guidance for 2023. We had a difficult start to 2022, but it is clear that we are trending up and in the right direction as we move into the new year,” said McEwen Mining chair and chief owner Rob McEwen in the press release.

To view the full press release, visit https://ibn.fm/Wm5Kx

About McEwen Mining Inc.

McEwen Mining is a gold and silver producer with operations in Nevada, Canada, Mexico and Argentina. In addition, it owns 68% of McEwen Copper, which owns the large, advanced-stage Los Azules copper project in Argentina. The company’s goal is to improve the productivity and life of its assets with the objective of increasing its share price and providing a yield. McEwen’s chair and chief owner has personally provided the company with $220 million and takes an annual salary of $1. To learn more about the company, visit www.McEwenMining.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by IT Brew, which delivers the latest news and analysis of trends shaping the IT industry, from cybersecurity and big data to software development. The piece discusses the post work-from-home (“WFH”) era and workers returning to the office with enhanced security setups. “In other words: The same security safeguards that protected users as they began working from home are still in effect in office environments. Software-defined networks (‘SD-WANs’), for example, enforced access control at home, and they’ll likely find a role in the office, according to Brian Haugli, CEO at the cybersecurity and privacy firm SideChannel,” the article reads, further quoting Haugli on this trend. “Now, with the return to the office, people are seeing the value out of software-defined networking, over having hardware-defined networking.”

To view the full article, visit https://ibn.fm/XY5BS

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, visit SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cerberus Sentinel (NASDAQ: CISO), a Scottsdale, Arizona-based industry leader as a managed cybersecurity and compliance provider, today announced plans for a corporate rebrand and launch. Central to the rebranding is a change of the company name to CISO Global, Inc. and an update to its corporate logo. “CISO Global was founded to bring cybersecurity professionals together on a global basis,” said David Jemmett, CEO and founder of CISO Global. “We have assembled a world-class leadership team, and we have successfully brought together 16 organizations globally. It is time for our name to reflect who we are as an organization.”

To view the full press release, visit https://ibn.fm/T5ElZ

About Cerberus Cyber Sentinel Corporation

Cerberus Sentinel is a global industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.ciso.inc.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

TAAT(R) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) has provided an overview of the company’s corporate developments for the last six months; that period covers the time since Michael Saxon, a 25-year veteran of the tobacco industry, was named CEO. The overview included the following: TAAT acquired the profitable distribution business ADCO Distributors Inc., an independent retail-focused business that has grown substantially to approximately C$90 million in revenues; the company has received three reorders from its London-based distributor, with the most recent reorder being the largest; and TAAT is in advanced conversations with distributors in three other European markets. The company also focused on its “home” market of Las Vegas, as well as San Diego, California, resulting in TAAT products being sold in more than 800 stores in Las Vegas and 500 locations in San Diego; TAAT also expanded its focus markets to include Texas, which included initial placements in all 34 Buc-ee’s locations in Texas. The Company announced the creation of a new subsidiary called Beyond Alternatives, which will begin to distribute other alternative products in growing categories. “These are exciting times for TAAT in the global tobacco industry, and I am very proud of what our team has achieved over the past six months; particularly the results we are seeing in our home market of Las Vegas,” said TAAT CEO Michael Saxon in the press release. “I’ve launched many tobacco brands in many markets for some of the largest players in the industry, and I am actively applying this experience to the commercialization of TAAT as a novel alternative to cigarettes for adult smokers who want to move on from tobacco and nicotine. We have also sought to establish a presence in settings where adult smokers tend to use tobacco products (e.g., smoking areas of performance venues, outdoor events such as festivals) so that we can engage consumers directly to gain trial. There are many exciting developments on the horizon for the year 2023, which I look forward to sharing as they occur.”

To view the full press release, visit https://ibn.fm/nbpHj

About TAAT Global Alternatives Inc.

TAAT develops, manufactures and distributes alternative products in categories such as tobacco, hemp, kratom and other emerging CPG segments. Its flagship product is a nicotine-free, tobacco-free combustible with a patent-pending base material formulation, sold in several thousand stores throughout the United States. TAAT has reported an estimated C$80-plus million in overall gross revenue annually and has an operations center in Nevada as well as a distribution center and multiple convenience stores in Ohio. For more information, please visit www.TAATGlobal.com.  

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at https://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector, is eliminating an estimated $10.5 million in debt. The company announced that its board of directors voted to approve the settlement of $10.475 million in debt related to arm’s length financing through the issuance of common shares at a price of $0.47 per share. According to the company, that pricing represents a premium of 370% to the company’s closing price per share on Dec. 20, 2022. Following the vote, RWBYF issued 22,440,467 common shares to creditors of the company, noting that all securities issued will be subject to a statutory hold period that expires four months and one day from the date of issuance. “We continue to strengthen our balance sheet and eliminate debt at favorable terms for the company,” said Red White & Bloom president and director Colby De Zen in the press release. “As evidenced by the tremendous progress already made this year on restructuring our balance sheet and expanding margin and the reach for our branded products, we are committed to growing our business, achieving our profitability goals, and building shareholder value.”

To view the full press release, visit https://ibn.fm/ePUHB

About Red White & Bloom Brands Inc.

Red White & Bloom is a multistate cannabis operator and house of premium brands in the U.S. legal cannabis sector. RWB is predominantly focusing its investments on the major U.S. markets, including Arizona, California, Florida, Massachusetts and Michigan. For more information about the company, please visit www.RedWhiteBloom.com. 

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at https://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SMBs are increasingly vulnerable to cyberattacks, from attacks on internal customer and employee records to proprietary secrets, and, although there are no foolproof solutions, there are now affordable and proven ways for SMBs to significantly mitigate the risks
• SideChannel’s team of vCISOs (virtual-based Chief Information Security Officer) possess a combined 400-plus years of experience in cybersecurity, offering creative solutions in the form of a bespoke cybersecurity program perfectly sized for growing enterprises
• The global cybersecurity market was valued at $139.77 billion in 2021 and is expected to reach $155.83 billion in 2022

The rapid digitization of supply chains creates serious new security risks. According to predictions by Gartner, 45% of organizations worldwide will have experienced cyberattacks on their software supply chains by 2025. With 60% of the current workforce working remotely, organizations are more vulnerable to attacks. They recommend that security leaders look beyond traditional approaches to security monitoring, detection, and response, to manage wider risks (https://ibn.fm/JnH6G).

SideChannel (OTCQB: SDCH) is simplifying cybersecurity for mid-market companies by matching them with highly experienced information security officers at a cost lower than building an in-house information security team or hiring a full-time…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

CubCrafters, the leading designer and manufacturer of light-sport, experimental and Part 23 certified backcountry aircraft, has announced its acquisition of Summit Aircraft Skis, including the company’s design and manufacturing assets, unique patents and related intellectual property, from the Sandpoint, Idaho-based Summit Aircraft Corporation. Favored by Carbon Cub owners, Summit Aircraft Skis are also preferred by the owners of many other types of non-CubCrafters manufactured backcountry capable aircraft. The unique ski design enables pilots to quickly and easily configure their aircraft to fly to many remote and primitive areas otherwise inaccessible in winter when runways are not maintained. “We are very excited and pleased to welcome Summit’s customers and products into our family here in Yakima,” said Patrick Horgan, CubCrafters president and CEO. “It has been a joy for our team to work together with Mike Custard, Summit’s founder, to coordinate a smooth ski manufacturing transition. Adding Summit Skis to the CubCrafters product lineup allows us to better meet our customers’ needs and adds a new profit center. We see a great potential for growth with the Summit brand that we want to be a part of going forward.”

To view the full press release, visit https://ibn.fm/kX1XA

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, today announced that it will be presenting at the Biotech Showcase on Monday, Jan. 9, 2023. Tryp’s presentation is slated to begin at 11 a.m. PT at the Hilton San Francisco Union Square Hotel in San Francisco, California. Interested parties should visit https://ibn.fm/dEhHP to attend the event. In addition, Tryp’s CEO Jim Gilligan and CBO Peter Molloy will be in San Francisco from Jan. 8-11, 2023, during the 41st Annual J.P. Morgan Health Care Conference and will be available for meetings with investors as detailed in the announcement.

To view the full press release, visit https://ibn.fm/kxOvb

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) that alleviates numerous shortcomings of oral psilocybin including: significantly reducing the time to onset of the psychedelic state, controlling the depth and duration of the psychedelic experience, and reducing the overall duration of the intervention to a commercially feasible timeframe. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Where a preliminary clinical benefit has been demonstrated, subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, today announced the results of its annual general meeting of shareholders. At the meeting, which was held in Hong Kong on Dec. 20, 2022, the company’s shareholders approved and ratified the appointment of Tiezhu (David) Zhang as a director of iClick.

To view the full press release, visit https://ibn.fm/R3GcB

About iClick Interactive Asia Group Limited

Founded in 2009, iClick is a leading enterprise and marketing cloud platform in China. iClick’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information, please visit ir.i-Click.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced it is rewarding all shareholders of record a digital coupon (“NFT”) redeemable for a gift package of company products valued at over $179 to drive shareholder engagement and additional revenue potential. According to the announcement, shareholders of record will be able to redeem the coupon to try the product first-hand or trade it with other fans globally on Upstream to bring new potential customers into the community. “By incorporating Upstream’s Web3 digital coupons into our strategy, we aim to provide our shareholders with first-hand experience of our products, which we hope will convert them into proud customers and brand ambassadors, driving additional engagement, revenue and sales to our company,” said Jupiter Wellness CEO Brian John.

To view the full press release, visit https://ibn.fm/60UqC

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For more information, visit the company’s website at www.JupiterWellness.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH), a provider of cybersecurity services and technology for emerging and middle market companies, reported on its fiscal year ended Sept. 30, 2022. Highlights of the report include revenue for the company reaching $4.8 million, a 71% increase over 2021, with vCISO revenue totaling $3.1 million, an increase of 93% over 2021. SideChannel’s recurring vCISO revenue reportedly increased by 562% and recurring software and services revenue increased by 367%. “Our 2022 performance demonstrates our continued strength and position in the market across both product and service delivery,” said SideChannel CEO Brian Haugli in the press release. “Our investments in sales and marketing, coupled with our expanding cybersecurity, privacy and risk management capabilities, have proven to be effective at acquiring new clients and retaining existing relationships.”

In addition, SideChannel CEO Brian Haugli, who previously served as a cyber security leader with the U.S. Department of Defense, was featured as an expert along with cyber security consultant Alana Staszcyszyn in a recent interview published by CBC News. The piece covers discussion regarding TikTok, which is owned by a Chinese company, and questions that are being raised as to whether the Chinese government might exploit the platform’s security issues. American lawmakers this week banned TikTok from U.S. government devices, and there is a proposal in the United States to ban it outright. “So, obviously, it’s a social media app that can be installed on Android or Apple phones and devices. I think that the primary issue with that is its ability to look at and see and store your location with GPS, the networks that you’re on, even be able to look at badge notifications,” Haugli said in responding to how concerned users should be about having the app on their devices. “So, if you get a message from a friend, your mom or someone else, it has the ability to read that because you granted those permissions to the TikTok application on your phone. And when you really kind of dig into all the permissions that are in there, I don’t think it’s something that most users are either aware of or willing to hand over to a company that’s owned and housed inside of China.”

To view the full press release and interview, visit https://ibn.fm/7Xzjc and https://ibn.fm/vKga9

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vistagen (NASDAQ: VTGN) is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other central nervous system (“CNS”) disorders. Today Vistagen, together with Pherin Pharmaceuticals, a clinical-stage drug development company focused on the discovery and development of investigational pherine compounds for treatment of neuropsychiatric and neuroendocrine conditions, announced entry into a definitive agreement. Under the agreement, Vistagen will acquire Pherin for approximately 12.4 million shares of Vistagen common stock and a nominal amount of cash. “Our confidence in the potential role of pherine compounds in fundamentally shifting the treatment paradigm for individuals living with anxiety, depression and several other disorders with unmet need has never been stronger,” said Shawn Singh, chief executive officer of Vistagen. “This transaction not only allows Vistagen to secure unencumbered global rights to a multi-asset pherine product pipeline and all future value from ownership of the pipeline, but it also establishes Vistagen as the market leader in the development and commercialization of this innovative class of small molecule drug candidates across a wide range of therapeutic areas.”

To view the full press release, visit https://ibn.fm/mlCkP

About VistaGen Therapeutics Inc.

Vistagen is a late clinical-stage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety, depression and other CNS disorders. The company is advancing therapeutics with the potential to be faster-acting, and with fewer side effects and safety concerns, than those that are currently available. Vistagen’s clinical-stage candidates are targeting multiple types of anxiety and depression. PH94B and PH10 belong to a new class of drugs known as pherines, which are designed with a novel rapid-onset mechanism of action that activates chemosensory neurons in the nasal passages and can impact the olfactory-amygdala neural circuits without systemic uptake or direct activity on CNS neurons in the brain. Vistagen is passionate about transforming mental health care and redefining what is possible in the treatment of anxiety and depression. For more information, visit the company’s website at www.Vistagen.com.

NOTE TO INVESTORS: The latest news and updates relating to VTGN are available in the company’s newsroom at https://ibn.fm/VTGN

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DSG Global (OTCQB: DSGT) wholly owned subsidiary Vantage Tag Systems has released a “statement of optimism” after a year of strategic acquisitions and new-product development along with booking an eight-figure order. According to the statement, the golf cart and low-speed vehicle (“LSV”) market is projected to grow at a CAGR of 8.2%, reaching $14.4 billion by 2027. Four-wheeled vehicles with a maximum speed of around 25 mph, LSVs have typically been used on golf courses; however, they are now being used as neighborhood and delivery vehicles and their use is expanding at industrial parks, college and university campuses, security patrols, hotels, amusement parks, airports, stadiums and gated golf communities. Vantage Tag is well positioned in this space and anticipates being able to take full advantage of the exploding LSV market. “We analyzed the market and made sure we had assembled a comprehensive suite of products to capitalize on both the commercial and consumer demand for LSV’s.” said Vantage Tag System CEO Bob Silzer in the press release. “We made a strategic acquisition for an iconic consumer cart brand that none of the incumbents can offer and also deliveries are available upon request. We made significant investments in new-product development of our own integrated GPS Management-enabled fleet carts and will be debuting the truly revolutionary SR1 single-rider cart at the upcoming PGA show in Orlando that has been engineered from scratch to address the holy grail of the golf industry; pace of play.”

To view the full press release, visit https://ibn.fm/pKFCB

About DSG Global Inc.

DSG Global was founded more than 12 years ago by the team that was one of the original pioneers of the GPS Golf Fleet Management industry. The company has two distinct brands to deliver on the explosive opportunities in the low-speed vehicle (“LSV”) and high-speed vehidle (“HSV”) markets. Liteborne Motor Company will address the HSV market with the new Aurium sport electric vehicle, along with many other vehicles in the pipeline, including buses and commercial vehicles. The LSV market will be supported and expanded by the established Vantage Tag Systems brand building on the 12-year track record of innovation in the marketspace with a comprehensive product lineup of GPS Fleet Management integrated carts for golf operators to the legendary Shelby golf carts, multipassenger carts and Shelby e-bikes. For more information about the company, please visit www.DSGTGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Gratomic (TSX.V: GRAT) (OTCQX: CBULF) (FRA: CB82), a multinational company with projects in Namibia, Brazil and Canada, announces that it has disposed of noncore assets in Namibia. In addition, the company was notified by the Namibian government that it qualified for a Valued Added Tax (“VAT”) refund from two previous VAT periods. Total proceeds from the disposal of noncore assets was NAD 3.20 million (CDN$251,178). The VAT refunds, which Gratomic anticipates receiving within the next two weeks, totaled NAD 3.15 million (CDN$247,253). That means that Gratomic expects to receive NAD 6.35 million (CDN$498,431) in the coming days.

To view the full press release, visit https://ibn.fm/iSXx7

About Gratomic Inc.  

Gratomic is a multinational company with projects in Namibia, Brazil and Canada. The company is focused on becoming a leading global graphite supplier and aims to secure a strong position in the electric vehicle (“EV”) battery supply chain. With the continued development of its flagship Aukam project and further exploration on its Capim Grosso property, Gratomic sets itself apart by seeking out unique top-quality assets around the world. True to its roots, the company will continue to explore graphite opportunities displaying potential for development. Gratomic ranked third place in the top-10 preforming mining stocks on the 2022 TSX Venture 50(TM). Large quantities of high-quality vein graphite have been shipped for testing to confirm its viability as an anode material. Gratomic is confident that the test results will provide a unique competitive advantage in its desired target markets. The company has formed a collaboration agreement with Forge Nano. With its patented Atomic Layer Deposition (“ALD”) rhis cooperation with Forge Nano is a key element to support Gratomic’s strategies toward the value-added phases of production of graphite for anode applications, namely micronization, spheronization and coating, making Gratomic graphite a preferred choice for use in lithium-ion batteries. For more information about the company, visit www.Gratomic.ca

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, is reporting on its second and third quarter of 2022. According to the company, the filing, which includes financial results along with operation highlights, brings Vivos current on SEC filings for NASDAQ stock market purposes. The reported stated that there have been no restatements of the June and September 2021 quarter results as a result of the company’s conclusions; consequently, Vivos is unable to make direct results comparisons between Q2 and Q3 2022 and the same quarters in 2021 because of the changes in application of the company’s revenue recognition policies between these periods. The report went on to observe that this inability would not continue in 2023 and that direct comparisons between 2023 and 2022 would be possible. “We are pleased to finally report our second and third quarter results and to have the revenue recognition review process behind us,” said Vivos chair and CEO Kirk Huntsman. “We are even more pleased that the net effect of this review is relatively minimal. While we continued to face some headwinds in 2022, we believe we have reacted prudently. We can now report that through a series of cost reduction initiatives, operational streamlining, and new revenue opportunities, we are moving towards our goal of achieving positive cash flow operations in the next 12 to 18 months.”

To view the full press release, visit https://ibn.fm/AREhp

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of more than 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

180 Life Sciences (NASDAQ: ATNF), a clinical-stage biotechnology company, has entered into a definitive agreement with a single healthcare-focused U.S. institutional investor. The agreement is for a registered direct offering to include the purchase and sale of 1,714,286 shares of the company’s common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to 2,571,429 shares of common stock at a purchase price per share (and accompanying warrant) of $3.50. According to the announcement, the warrants will have an exercise price of $3.50 per share, will be initially exercisable beginning six months following the date of issuance and will expire five years from the initial exercise date. The offering will total an estimated $6 million. The company anticipates the offering to close this week. ATNF plans to use the net proceeds for R&D and general corporate purposes, including the preparation of a marketing authorization application and legal expenses. Alliance Global Partners is acting as the sole placement agent for the offering.

To view the full press release, visit https://ibn.fm/LCGhf

About 180 Life Sciences Corp.

180 Life Sciences is a clinical-stage biotechnology company driving groundbreaking studies into clinical programs that are seeking to address major unmet medical needs. The company’s focus is a novel program to treat several inflammatory disorders using anti-TNF (tumor necrosis factor). For more information about the company, visit www.180LifeSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to ATNF are available in the company’s newsroom at https://ibn.fm/ATNF 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel (OTCQB: SDCH) was featured in a recent article published by Built in Boston, the online community for Boston startups and tech companies. The piece discusses SideChannel’s success in growing its revenue by 114% over the past year and its business strategy of renting chief information security officers(“CISOs”) to startups. “Worcester-based SideChannel’s mission is to give every company access to the benefits of having a CISO without the cost of a full-time hire. The cybersecurity company evaluates an organization’s needs and matches the business with a virtual chief information security officer (‘vCISO’) that has enterprise-level experience,” the article reads. Further quoting SideChannel’s founder and CEO Brian Haugli on the innovative approach, he states, “Knowing that mid-market firms do not have the financial resources of larger enterprises, what if I could make CISOs fractionally available to them? Even better, what if these virtual CISOs were once actually CISOs with enterprise experience?”

To view the full article, visit https://ibn.fm/Tqvoi

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of over 400 years in the industry. To date, SideChannel has created more than 50 multi-layered cybersecurity programs for its clients. Learn more at SideChannel.com.

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

InnerScope Hearing Technologies (OTC: INND), an emerging and disruptive leader in the over-the-counter (“OTC”) hearing aid space, today announced its entry into a memorandum of understanding (“MOU”) with NUHEARA Limited (ASX: NUH), a medical device and consumer electronics manufacturer listed on the Australian Stock Market. “We are excited to work with NUHEARA’s management team to build a strong partnership,” said InnerScope CEO and President Matthew Moore. “This partnership gives NUHEARA access to InnerScope’s distribution network. In addition, the partnership gives InnerScope the ability to integrate NUHEARA’s FDA-Cleared OTC Self-Fitting Hearing Aid Patent Technology (‘FDA-Cleared Self-Fitting Technology’) into InnerScope’s HearingAssist and iHEAR OTC Hearing Aid branded products (‘InnerScope’s brands of OTC Hearing Aid products’). Integrating the FDA-Cleared Self-Fitting Technology into InnerScope’s brands of OTC Hearing Aid products will provide InnerScope the ability to offer and market InnerScope OTC Hearing Aids as FDA-Cleared Self-Fitting Hearing Aids. In addition, we are equally excited to have NUHEARA give InnerScope status as the exclusive third-party distributor who can market and sell the HP Hearing PRO FDA-Cleared Self-Fitting OTC Hearing Aids through InnerScope’s distribution network. The HP brand is a well-known and respected brand, and we are proud to add the HP Hearing PRO powered by NUHEARA into InnerScope’s brands of OTC Hearing Aid products.”

To view the full press release, visit https://ibn.fm/r9Zup

About InnerScope Hearing Technologies Inc.

InnerScope is a manufacturer and distributor of OTC hearing aids, hearing aid accessories and hearing health-related products (“hearing products”) dedicated to addressing the global demand for affordable hearing solutions. InnerScope’s hearing products and its B2C and B2B business model break through the persistent barriers that prevent access to effective and affordable hearing solutions. InnerScope’s recent acquisition of iHear Medical Inc., a direct-to-consumer (“DTC”) cloud-based hearing solution provider, gives the company access to over 40 patents and an R&D facility. In addition, InnerScope has acquired HearingAssist, an established leader since 2008 in the DTC hearing aid market, with a customer base of over 400,000. These acquisitions, combined with a partnership with Atlazo Inc., a semiconductor innovator for next-generation AI smart devices, will allow InnerScope to better position itself in the OTC hearing aid market by selling advanced hearing products through Walmart and many other major retailers and pharmacy chains. InnerScope’s full line of hearing products is currently available through these multiple retail/wholesale distribution channels: Walmart Vision Centers, Walmart.com, Walmart Canada, CVS.com, RiteAid.com, BestBuy.com, Amazon.com, Fingerhut.com, Giant Eagle, Hy-Vee, Hartig Drug, Food City, Cardinal Health(TM) at-Home, Carewell.com, FSAStore.com , HSAStore.com, WellDeservedHealth.com, and Topco Associates, representing 1000s of stores. Coming soon: Wakefern Food Corp. / ShopRite / SpartanNash / VG’s Grocery / Family Fare / Martin’s Super Markets. More in-store and online hearing products will soon launch with major retailers and pharmacy chains. For the most up-to-date information about InnerScope, please visit and follow its official Twitter account @inndstock page: https://twitter.com/inndstock.

NOTE TO INVESTORS: The latest news and updates relating to INND are available in the company’s newsroom at https://ibn.fm/INND

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

iClick Interactive (NASDAQ: ICLK), a leading enterprise and marketing cloud platform in China that empowers worldwide brands with full-stack consumer lifecycle solutions, reported that its board of directors has received a preliminary nonbinding proposal to acquire the company. Dated Dec. 20, 2022, the proposal letter is from the following companies: Igomax Inc., a British Virgin Islands company wholly owned by Jian Tang, ICLK chair of the board, CEO and company cofounder; Bubinga Holdings Limited, a British Virgin Islands company wholly owned by Wing Hong Sammy Hsieh, a director and company cofounder; and Rise Chain Investment Limited, a British Virgin Islands company wholly owned by Huang Jianjun. The proposal includes acquiring all ICLK outstanding ordinary shares and American depositary shares, other than those already owned by the three companies, or the consortium, for $4.0672 per ADS in cash, or $0.81344 per ordinary share; the transaction is subject to terms and conditions outlined in the proposal letter. According to the announcement, the consortium beneficially owns ICLK ordinary shares representing approximately 63% of the aggregate voting power of the company. The announcement also noted that a special committee of the board will evaluate the proposed transaction. “The board cautions the company’s shareholders and others considering trading the company’s securities that the board has just received the proposal letter, and the special committee has not had an opportunity to carefully review or evaluate the proposal or make any decision with respect to the company’s response to the proposal,” the company stated in the press release. “There can be no assurance that any definitive offer will be made, that any definitive agreement will be executed relating to the proposed transaction, or that the proposed transaction or any other transaction will be approved or consummated.”

To view the full press release, visit https://ibn.fm/1Aj6i

About iClick Interactive Asia Group Limited

iClick is a leading enterprise and marketing cloud platform in China. The company’s mission is to empower worldwide brands to unlock the enormous market potential of smart retail. With its leading proprietary technologies, iClick’s full suite of data-driven solutions helps brands drive significant business growth and profitability throughout the full consumer lifecycle. Headquartered in Hong Kong, iClick currently operates in 11 locations across Asia and Europe. For more information about the company, please visit www.iClick.com.

NOTE TO INVESTORS: The latest news and updates relating to ICLK are available in the company’s newsroom at http://ibn.fm/ICLK

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SPYR (OTCQB: SPYR), a diversified technology company developing products leveraging the Internet of Things (IoT) for consumer use and large-scale applications and industries, has entered into a settlement agreement and release with Berkshire Capital Management Co. Inc. and Joseph Fiore. The agreement outlines the cancellation of 36,272,684 total common shares, with Berkshire agreeing to cancel 33,831,508 common shares and Fiore agreeing to cancel 2,441,176. The cancellations were made in exchange for a release of claims of outstanding legal claims between the parties. “I am pleased to report the cancellation of these shares representing over 10% of our current issued and outstanding shares,” said SPYR CEO Timothy Matula in the press release. “The company entered into this agreement to resolve outstanding legal claims between it and Berkshire and Fiore. I am glad to have resolved the company’s claims in an informal matter that terminates Berkshire and Fiore’s beneficial ownership in these shares, and returns them to treasury.”

To view the full press release, visit https://ibn.fm/cqlu0

About SPYR Inc.

SPYR Technologies is a technology company focused on IoT, or the Internet of Things. Through its subsidiary GeoTraq business, SPYR develops and manufactures fully self-contained, ultra-small mobile IoT modules: Trackertracker-M modules for asset tracking and location-based services, and Sensorsensor-M modules used for remote monitoring. SPYR continues to identify and target acquisitions that will grow its footprint in the industry and expand the products it offers consumers, including companies developing artificial intelligence (“AI”) and smart-technology products. For more information about this company, visit https://ir.spyr.com.

NOTE TO INVESTORS: The latest news and updates relating to SPYR are available in the company’s newsroom at https://ibn.fm/SPYR

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced an expanded partnership between its subsidiary U.S. Hybrid and Toyota Tsusho America Inc. To accelerate the use of zero-emission hydrogen in port drayage operations, the parties are commencing the second phase of collaboration under which U.S. Hybrid will retrofit a second Top Pick Stacker, replacing diesel engines and drive trains with a new hydrogen fuel cell system. “This collaboration is special for me because Ideanomics gets to help create a better life for communities next to ports, where too many people are still breathing air full of toxic diesel pollution,” said Robin Mackie, president of Ideanomics Mobility. “The work doesn’t stop here. U.S. Hybrid is ready to help more port drayage fleet operators transition to zero-emission without breaking the bank or disrupting duty cycles. Few companies do what we do, and even fewer have the same proven track record of safe, on-time vehicle and equipment conversion.”

To view the full press release, visit https://ibn.fm/Lt31Z

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), a U.S.-based uranium mining and exploration company, has been awarded a $17.85 million order from the U.S. Department of Energy (“DOE”) – National Nuclear Security Administration (“NNSA”) to supply 300,000 pounds of U.S.-origin uranium concentrates at $59.50 per pound. UEC was awarded the order after responding to the NNSA’s Request for Proposals (“RFP”) to establish its strategic national Uranium Reserve program. U.S. officials have called the Uranium Reserve an important step in helping to rebuild America’s nuclear fuel capabilities and revitalizing U.S. capability to fuel its existing reactor fleet as well as new advanced reactors. The Uranium Reserve was originally designed as a 10-year, $1.5 billion plan to help revitalize the domestic uranium and conversion industry. UEC’s award is part of an initial $75 million authorized by Congress in 2020 to advance the government’s goal of supporting America’s nuclear fuel supply chain and capabilities. According to the announcement, UEC plans to deliver the order via book transfer in Q1 2023. “We are honored and delighted to be selected as a domestic producer for this purchase of uranium concentrates by the NNSA and look forward to the further expansion of the Uranium Reserve program in the coming years,” said Uranium Energy president and CEO Amir Adnani in the press release. “The U.S. nuclear reactor fleet that provides about 20% of America’s electricity production, and over half of its clean energy, imports nearly 60% of its current uranium requirements from Russia , Kazakhstan and Uzbekistan . The U.S. overdependence on these imports creates untenable energy and national security risks that need immediate high-priority attention from industry and the federal government.”

To view the full press release, visit https://ibn.fm/5r6Vr

About Uranium Energy Corp.

Uranium Energy Corp is the fastest-growing supplier of the fuel required for green-energy transition to a low-carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub-and-spoke platforms in south Texas and Wyoming, anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, UEC has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American-warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource-stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about the company, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC 

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

AnPac Bio-Medical Science (NASDAQ: ANPC), a biotechnology company with operations in the United States and China, is reporting its unaudited financial results for the six months ended June 30, 2022. Highlights of the report for the first half of 2022 include total revenue of an estimated $778,000, a decrease of 43.7% compared to the same period of 2021, and gross profit margin for the same period of 64.9%, up from 61.4% for the same period of 2021. The report also noted that the average selling price of CDA-based tests was $36.8) for the six-month period, down 50.9% from the same period in 2021; the company noted that the decrease was primarily due to focusing on more conventional cancer detection tests at lower prices. Net loss for the first half of 2022 was an estimated $7.3 million, a 15.4% decrease from the same period in 2021; the company attributed the change to selling and marketing expenses, R&D expenses, general and administrative expenses, and impairment of intangible assets and good will. The report also noted non-GAAP net loss of approximately $6.6 million, an increase of 18.6% compared with the same period of 2021. Business highlights from the report included continued validation regarding the efficacy of CDA testing through clinical study follow-ups and progress on patent development: As of June 30, 2022, AnPac had filed 260 patent applications globally, with 155 patents being granted, including 22 patents granted in the United States, 68 in greater China (including eight in Taiwan), and 65 in other countries and regions. The company is continuing to build its cancer-risk assessment database, which currently includes  some 270,361 samples. AnPac also delivered an aggregate of 8,074,594 shares reserved for convertible debentures in principal balance of approximately $3.5 million by June 30, 2022, at conversion prices ranging from $0.16 to $1 per share. The company also issued 6 million shares as reserve for potential convertible loans conversion in the first quarter of 2022. “The first half year of 2022 was challenging due to COVID-19, especially in Shanghai area between early March to early May 2022, which affected our business and resulted in reduced paid cancer tests and hence revenue,” said AnPac Bio co-CEO Dr. Chris Yu in the press release. “However, we had a very strong June 2022 in paid cancer tests. We have also made significant efforts in reducing our costs including head counts, which has been effective and resulted in our reduced loss. We continue to advance our CDA technology in a number of areas including our multiyear follow-up study in enrolled individuals who had CDA tests. We reported multiyear clinical trial results in our CDA technology for lung cancer treatment prognosis in April’s American Association for Cancer Research conference. . . . In addition, due to our strong cost-reduction efforts in the first half of year, we expect that our costs will continue to reduce and loss will further narrow.”

To view the full press release, visit https://ibn.fm/0yxAC

About AnPac Bio-Medical Science Co. Ltd.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 155 issued patents as of June 30, 2022. With two certified clinical laboratories in China and one CLIA- and CAP-accredited clinical laboratory in the United States, AnPac Bio performs a suite of cancer-screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a report by Frost & Sullivan, AnPac Bio ranked first globally in multicancer screening and detection-test sample volume, accumulative to January 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Small to medium-sized businesses (“SMBs”) face potentially prohibitive costs when it comes to hiring full-time cybersecurity experts 
• Despite the costs concern, the need is growing, as malicious computer experts often turn to SMBs and organizations as easy prey because of the smaller companies’ lack of experience, budget, and infrastructure necessary to ward off computer network invasions
• A San Diego school district recently reported its employees’ personal data was compromised in a cyberattack, and a Los Angeles school district reported it received a ransom demand after its computer files were seized in September and then published on the dark web
• SideChannel Inc. is helping SMBs to bridge the cybersecurity cost divide by offering virtual chief information security officers (“vCISOs”) as a contracted service that is more affordable than an in-house employee

When the San Diego Unified School District acknowledged recently that the personal information of many current and former employees was taken by unknown actors in a cybersecurity incident, it established that potentially malicious individuals have turned to public school systems in the latest reports of computer breaches.

NBC affiliate KNSD reported that prior to the incident in San Diego, a number of cybersecurity incidents involving schools and health care systems had been reported in California, including an attack on The Los Angeles Unified School District in September that locked up the district’s files and demanded a…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Cerberus Sentinel (NASDAQ: CISO) is an industry leader as a managed cybersecurity and compliance provider based in Scottsdale, Arizona. This positions the company in a rapidly growing sector, with Cybersecurity Ventures projecting that cybercrime damages will cost the world a whopping $8 trillion in 2023 in an expected upward trend. “We predict that global cybercrime damage costs will grow by 15% per year over the next three years, reaching $10.5 trillion USD annually by 2025, up from $3 trillion USD in 2015,” reads a recent article published by Cybersecurity Ventures. “The 2022 Official Cybercrime Report published by Cybersecurity Ventures and sponsored by eSentire, provides cyber economic facts, figures, predictions and statistics, which convey the magnitude of the cyber threat we are up against, and market data to help understand what can be done about it.”

To view the full article, visit https://ibn.fm/CByE0

About Cerberus Cyber Sentinel Corporation

Cerberus Sentinel is an industry leader as a managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CerberusSentinel.com.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Uranium Energy (NYSE American: UEC), the fastest growing supplier of the fuel for green energy transition to a low carbon future, today reported, in accordance with NYSE American requirements, the filing of the company’s quarterly report on Form 10-Q for the quarter ended Oct. 31, 2022, with the U.S. Securities and Exchange Commission (the “SEC”). The Form 10-Q filing, which includes UEC’s interim condensed consolidated financial statements, related notes and management’s discussion and analysis, is available for viewing on the SEC’s website or the company’s website. “This most recent quarter validates UEC’s growth strategy and our strengths and unique abilities as a pure-play, 100% unhedged uranium supplier,” said the company’s CEO and President Amir Adnani. “Supported by our strong balance sheet and physical portfolio, we are advancing a two-pronged approach, combining best in-class: 1) U.S. in-situ recovery (‘ISR’) production anchored by two processing plants; and 2) Canadian high-grade conventional development pipeline. The company’s North American warehoused physical portfolio is enabling opportunistic and profitable spot market sales and will be a reliable long-term source of supply.”

To view the full press release, visit https://ibn.fm/QXNC4

About Uranium Energy Corp.

Uranium Energy is the fastest growing supplier of the fuel for the green energy transition to a low carbon future. UEC is the largest, diversified North American-focused uranium company, advancing the next generation of low-cost, environmentally friendly in-situ recovery (“ISR”) mining uranium projects in the United States and high-grade conventional projects in Canada. The company has two production-ready ISR hub and spoke platforms in South Texas and Wyoming. These two production platforms are anchored by fully operational central processing plants and served by seven U.S. ISR uranium projects with all their major permits in place. Additionally, the company has diversified uranium holdings including: (1) one of the largest physical uranium portfolios of North American warehoused U3O8; (2) a major equity stake in Uranium Royalty Corp., the only royalty company in the sector; and (3) a Western Hemisphere pipeline of resource stage uranium projects. The company’s operations are managed by professionals with decades of hands-on experience in the key facets of uranium exploration, development and mining. For more information about UEC, visit www.UraniumEnergy.com.

NOTE TO INVESTORS: The latest news and updates relating to UEC are available in the company’s newsroom at https://ibn.fm/UEC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

DarioHealth (NASDAQ: DRIO), a leader in the global digital therapeutics (“DTx”) market, is reporting the publication of a new study in “Frontiers in Physiology,” a peer-reviewed journal; the study shows the effectiveness DRIO’s musculoskeletal solution, which uses real-time biofeedback and behavior training to reduce back pain. According to the announcement, the study evaluated retrospective data from 981 individuals who used Dario Move’s posture trainer for at least eight weeks, focusing on the relationship between the amount of time spent training, the use of the device and reduction in back-pain levels. Results indicated that, on average, users reported a 50% reduction in pain, with 60% of users reporting clinically important pain reduction after four weeks of biofeedback training; that number increased to 76% of users showing some pain reduction after eight weeks. Dario’s Move posture training solution involves a wearable biofeedback device and real-time data feedback. The device is designed to vibrate when the user slouches, which develops awareness and encourages proper posture. “Addressing chronic pain with posture training is known to have a positive impact on pain, and now we are able to better define that relationship and the role of the device,” said Dario vice president of clinical and scientific affairs Yifat Hershcovitz, PhD. “We are thrilled to demonstrate our ability to use real-time data from the sensor to drive healthier musculoskeletal health behaviors through ongoing training is now positively linked clinical outcomes.”

To view the full press release, visit https://ibn.fm/UzHlA

About DarioHealth Corp.

DarioHealth Corp. is a leading digital therapeutics (DTx) company revolutionizing how people with chronic conditions manage their health through a user-centric, multichronic condition platform. Dario’s platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company’s user-centric platform offers people continuous and customized care for health, disrupting the traditional episodic approach to healthcare. This approach empowers people to holistically adapt their lifestyles for sustainable behavior change, driving exceptional user satisfaction, retention, and results. Dario provides its highly user rated solutions globally to health plans and other payors, self-insured employers, providers of care and directly to consumers. For more information about the company, please visit www.DarioHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to DRIO are available in the company’s newsroom at http://ibn.fm/DRIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a company focused on hair, skin and sexual wellness, today announced that SRM Entertainment has filed a registration statement with the Securities and Exchange Commission to separate the company. Upon completion of the spinoff, SRM and Jupiter Wellness will operate as two independent and separate public companies, with Jupiter Wellness expected to remain the majority shareholder of SRM. “SRM is a nuts-and-bolts business; the more capital we have to turn, the faster we will grow,” said SRM CEO Richard Miller. “This IPO of SRM to the NASDAQ will provide us with the capital to continue our revenue growth while giving loyal Jupiter Wellness shareholders a stock dividend in SRM Entertainment.”

To view the full press release, visit https://ibn.fm/lJ0hw

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements and licensing royalties. For more information, visit the company’s website at www.JupiterWellness.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli authored an article for the Cyber Defense magazine. The piece, titled “Micro-Segmentation: Where Does It Fit into Zero Trust?”, discusses a zero trust, a recent buzzword that is a concept not a technology, Haugli explained. He also notes that zero trust is not micro-segmentation, and he cautions companies not to be misled by vendors that tout that an implementation of a micro-segmentation solution equates to having a zero trust environment. Zero trust, says Haugli, “is a strategic initiative to create least privilege across all aspects of an organization. It requires the three elements of the triad in any program: people, process and technology. You generally need an inventory of the users in the environment, the applications in place and the supporting infrastructure.  Without that inventory, a move towards zero rrust will be impossible.” He also goes on to observe that the basic requirement of micro-segmentation is expressly allow traffic from a source to a destination and deny all other traffic. “It’s one thing to build a program based on standards, but we must factor in the threats that are present that the program is built to reduce or stop,” wrote SideChannel CEO Brian Haugli in the article. “Cyber isn’t just addressing the defensive needs or accounting for the offensive threats. Ransomware is prevalent in our society today and an all-too-common news story both locally and nationally.  When we look at why it’s so destructive, it’s not the encryption of one system that causes the pain, it is that the impact is across so many systems. This is allowed to happen from flat networks or lack of segmentation between work groups.  A properly implemented micro-segmentation technology coupled with a strong managed policy would significantly reduce or even stop ransomware’s lateral movement across an environment. . . . The first question to answer is whether you have a cyber program built to a standard, such as NIST CSF. Then it’s onto how your organization meeting is each of the applicable controls.  As you define your remediations and mitigations, a micro-segmentation solution should make its way into your plan to address identified gaps in controls.  These are your first steps in the march towards zero trust.”

To view the full article, visit https://ibn.fm/GrMC3

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• With high-profile hacks abounding in 2022, Gartner forecasts that by 2025, 80% of enterprises will have adopted a strategy to unify web, cloud services, and private application access from a single vendor’s SSE platform
• Data443 Risk Mitigation offers a comprehensive and diverse software-as-a-service portfolio for data protection that is trusted by some of the world’s biggest companies
• During the first nine months of 2022, Data443 reported $2.3 million in revenue and $2.7 million in deferred revenue as it transitions customers from a one-time payment model into a recurring revenue model

As 2022 winds down, another year of lessons about data protection is in the books, alongside a year’s worth of notable breaches that made cybercriminals rich while costing economies and businesses billions of dollars. Teenage hacker group Lapsus bursts on the scene, hacking some of the world’s biggest companies, including Microsoft and Samsung. Vice Society hacked the U.S.’s second-biggest school district. Crypto video game company Axie Infinity was pillaged by cybercriminals to the tune of $620 million. Even hackers weren’t safe. Nefarious ransomware group Conti was penetrated by Ukrainian “hacktivists” that released internal content showing how they conduct their criminal enterprise.

2023 will likely be distinguished by a growing number of approaches using consolidated cybersecurity architecture and multi-layer approaches to protect against criminals who are notoriously adept at prying their way through any weakness, like a sentinel in the Matrix. Through strategic acquisitions…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF), the digital face of the plant-based community operating a one-stop shop for plant-based products, is releasing an update on its delay in filing required annual financial statements, management’s discussion and analysis, and related certifications for the fiscal year ended March 31, 2022; the update also included the filing status of its financial statements, management’s discussion and analysis, and related officer certifications for the three-month period ended June 30, 2022 as well as filing the required documents for the six-month period ended Sept. 30, 2022. According to the announcement, PLTXF’s 2022 audit is ongoing but has been delayed because the company has had to complete and restate its fiscal year required documents for March 31, 2021; the company is also implementing internal control procedures as a result of the restatement process. “Trading in the company’s securities currently remains subject to a general ‘failure to file’ cease trade order issued on Oct. 18, 2022, by the British Columbia Securities Commission,” the company stated in the announcement. “The company is working diligently with the auditors to complete and file the annual filings and the interim filings and expects to have the audit of the annual filings completed, and the annual filings filed, within a few business days. The company expects the interim filings to be filed concurrently with or shortly after the filing of the annual filings. The company is currently not subject to any insolvency proceedings and there is no other material information concerning the affairs of the company that has not generally been disclosed.”

To view the full press release, visit https://ibn.fm/NzTRR

About PlantX Life Inc.

PlantX is committed to being the digital face of the plant-based community as well as the one-stop shop for everything plant based. With its fast-growing category verticals, the company offers customers across North America more than 5,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand. But the business is not limited to an ecommerce platform. PLTXF uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information about this company, please visit www.PlantX.com and www.PlantX.ca.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

CubCrafters, a best-in-class backcountry aircraft producer, is leveraging the anticipated growth of the light and ultralight aircraft market. The sector is projected to grow from $7.5 billion in 2022 to $11.9 billion in 2030, driven by the increasing number of backcountry enthusiasts. “‘Light aircraft’ is classified as any aircraft with a maximum gross takeoff weight of 12,500 pounds or less and most commonly used for general aviation purposes,” a recent article explains. “The company focuses on four main product lines – the Carbon Cub FX, NXCub, XCub, and Carbon Cub EX kits. The models are built to be lightweight and powerful, with some emphasizing short takeoff and landing capabilities and others built for longer missions in unforgiving backcountry environments. Dominating this sector, the company has developed seven models that emphasize flexibility, including varied landing gear configurations such as nosewheel, tailwheel, floats, and skis… In August, the company debuted a new lightweight engine for its Carbon Cub model, improving the CC340 that made previously unheard-of short takeoff and landing performance possible for backcountry enthusiasts. The new CC363i F/P is a higher displacement fuel-injected engine with more horsepower than the CC340, according to CubCrafters.”

To view the full article, visit https://ibn.fm/lvP3s

About CubCrafters Inc.

Founded in 1980 by Jim Richmond, CubCrafters’ roots are in the 80+ year history of classic grassroots aviation, but the company’s products and services are innovative and completely modern. CubCrafters designs and manufactures experimental, LSA, and Part 23 certified aircraft. The Carbon Cub family of aircraft redefined expectations for the backcountry flying experience with innovative design, modern materials, powerful engines, and breathtaking performance. The company’s flagship XCub aircraft is offered in both nosewheel and tailwheel configurations, and substantially expands the mission profile of sport utility aircraft with higher speed, longer range and larger payload. The key to CubCrafters’ success is its ability to create unique value in the experience of personal adventure aviation. For more information about the company, visit www.CubCrafters.com.

NOTE TO INVESTORS: The latest news and updates relating to CubCrafters are available in the company’s newsroom at https://ibn.fm/CUB

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF) today announced that it released a new and updated version of lqwd.tech, the company’s proprietary, non-custodial Lightning Network (“LN”) software-as-a-service (“SaaS”) platform. The platform is designed for institutions, businesses and users to easily integrate and utilize the Lightning Network, which allows for millions of Bitcoin transactions to be made in seconds. “We are very excited for the release of the updated version of our Lightning Network platform, lqwd.tech,” said the company’s CEO Shone Anstey. “We have learned a lot and made vast improvements to the platform, and LQwD as a company has become a key player on the Lightning Network through its global routing nodes and our easy to use platform.”

To view the full press release, visit https://ibn.fm/3xbFr

About LQwD FinTech Corp.

LQwD is a Lightning Network Service Provider (“LSP”) focused on developing payment infrastructure and solutions accelerating the global mega trend of Bitcoin adoption through the Lightning Network. The company’s mission is to develop institutional grade services that support the Lightning Network and drive improved functionality, transaction capability, user adoption and utility and scaling Bitcoin. LQwD also holds Bitcoin that is used as an operating asset, establishing nodes and payment channels on the Lightning Network.

NOTE TO INVESTORS: The latest news and updates relating to LQWDF are available in the company’s newsroom at https://ibn.fm/LQWDF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Golden Triangle Ventures (OTC: GTVH) (“GTV”) today announced an end-of-the-year update to provide an overview of all current operations within the business, including several new developments. After one of its most challenging years, GTV management has refocused priorities intended to set the course for a promising outlook into 2023 and beyond. “This year has been one of the most valuable years our company has ever faced. Our focus and priority is to execute and deliver countless energy contracts that are believed to provide our company with a strong financial opportunity upon completion,” said Steffan Dalsgaard, CEO of Golden Triangle Ventures. “While navigating through one of the biggest opportunities of our lifetime, we are confident in our ability to deliver a success within our energy endeavors. Following this, we are excited to build out The Wellness Club with Dr. Dan Jurgens and prove a business model that we aim to develop into a highly profitable business. In addition, we have been actively working on a plan throughout this past year to develop a Luxury Real Estate business that aims to bolster several of the divisions within GTV. OTC Markets is currently in review of our recently submitted application in order to get current in our reporting obligations and the company has been actively preparing for its anticipated audit and expansion plans. With countless opportunities that are all being strategically implemented within the best of our ability, we are greatly looking forward to 2023 as I believe the stage is now being set to deliver fundamental growth, substantial accomplishments, and true value to all of our shareholders in the year ahead.”

To view the full press release, visit https://ibn.fm/ekLw1

About Golden Triangle Ventures Inc. (“GTV”)

Golden Triangle Ventures is a multifaceted consulting company pursuing ventures in the health, entertainment, technology, fulfillment, and food and beverage industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can assist and help develop into unique opportunities. Additionally, GTV provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion for and commitment to these marketplaces. The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. For more information, visit the company’s website at www.GoldenTriangleInc.com.

NOTE TO INVESTORS: The latest news and updates relating to GTVH are available in the company’s newsroom at https://ibn.fm/GTVH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, anticipates releasing its second and third quarter 2022 financial results on Dec. 20, 2022. The information will be released after market close. The company will also hold a conference call and live webcast the same day at 5 p.m. During the call, company leaders will provide an overview of its results along with milestones and developments for the two quarters. Those interested can access the call by dialing 877-451-6152; international callers may dial 201-389-0879. A replay of the call will also be available until Jan. 3, 2023; that replay can be accessed by dialing 844-512-2921 or 412-317-6671 for international callers. All callers will use passcode 13734946.

To view the live webcast, visit https://ibn.fm/SasKp

To view the full press release, visit https://ibn.fm/z9cSW

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of an estimated 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• CISO looking to accelerate growth in Latin America
• NLT Secure provides a broad range of security solutions and managed services to organizations throughout South America
• Earlier this year, the company closed on the acquisition of CUATROi

As part of its strategic plan to expand into South America, Cerberus Cyber Sentinel (NASDAQ: CISO) has completed the acquisition of NLT Secure, a cybersecurity company with headquarters in Providencia, Chile, and U.S. offices in Tampa, Florida (https://ibn.fm/zhJjg); NLT Secure will become a wholly owned subsidiary of Cerberus Sentinel, a cybersecurity services firm.

“NLT Secure accelerates our growth strategy into Latin America and is an excellent cultural fit,” said Cerberus Sentinel CEO and founder David Jemmett. “As cybersecurity continues to be a global challenge requiring a breadth of capabilities, NLT has made this its mission to help secure businesses and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Brain Scientific (OTCQB: BRSF), a Florida-based applied science technology company, has announced a new distribution agreement with MVAP Medical Supplies to pursue the rapidly growing and underserved pediatric EEG marketplace. According to the announcement, MVAP Medical Supplies, an industry leader in the sleep, EEG, EMG, IOM, respiratory and patient care supplies space, will help Brain Scientific further expand its sales and distribution network to key growth markets. “We designed the NeuroCap to be game-changing in the neurodiagnostic wearable space. It has critical applications in pediatrics, emergency and ICUs, at-home care and research,” said Hassan Kotob, CEO of Brain Scientific. “We are excited to have MVAP Medical Supplies with us on our journey to becoming the leading medical wearables provider on the planet.”

To view the full press release, visit https://ibn.fm/MAg7t

About Brain Scientific Inc.

Brain Scientific is an applied sciences technology company with multiple patents and FDA-cleared products. Brain Scientific is committed to developing next-gen solutions that advance the future of medical and OEM devices. Brain Scientific has two product lines covering neurology and precision motion. The NeuroCap(TM) and NeuroEEG(TM) are smart neurological diagnostic devices that simplify administration, shorten scan time and cut costs. The Piezo Motion product line consists of ultra-efficient compact precision motors that will drive the next generation of OEM devices. To learn more about Brain Scientific’s corporate strategy, products or investor relations, please visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at https://ibn.fm/BRSF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Genprex (NASDAQ: GNPX) is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. The company has announced that the Safety Review Committee (“SRC”) approved continuation to the third and final cohort in the dose escalation Phase 1 portion of the Acclaim-1 Phase 1/2 clinical trial of REQORSA(R) in combination with Tagrisso(R) (osimertinib) to treat late-stage non-small cell lung cancer (“NSCLC”). In 2020, the REQORSA/osimertinib combination received U.S. Food and Drug Administration’s (“FDA”) Fast Track Designation for treatment of the Acclaim-1 patient population. “The SRC’s recommendation to increase the dosing of REQORSA is further confirmation of its favorable safety profile and it enables us to advance Acclaim-1 into the final cohort of the Phase 1 dose escalation portion of the study,” said Genprex Chief Medical Officer Mark Berger, M.D. “We look forward to completing enrollment of this final cohort in the first quarter of 2023.”

In addition, the company today announced its entry into a license agreement with the University of Pittsburgh. The agreement grants Genprex a worldwide, exclusive license to certain patent applications and related technology and a worldwide, non-exclusive license to use certain related know-how, all related to modulating autoimmunity in type 1 diabetes by using gene therapy. “Gaining exclusive access to technology that modulates the immune system by transforming macrophages could prove to be significant to our broader research partnership with the laboratory of George Gittes, MD, Professor of Surgery and Pediatrics and Chief of the Division of Pediatric Surgery at the University of Pittsburgh School of Medicine,” Genprex CMO Dr. Berger said in the news release. “We are making significant strides in our program with Dr. Gittes’s innovative approach to treating diabetes by the transformation of alpha cells into beta-like cells and are excited to add to our arsenal this additional technology also out of Dr. Gittes’s lab, in collaboration with the laboratory of Dr. Xangwei Xiao, Assistant Professor of Surgery, also in the Division of Pediatric Surgery at the University of Pittsburgh’s School of Medicine. Not only could this new approach be used to reduce autoimmune activity in type 1 diabetes by modulating the immune system, but potentially it could also work in conjunction with the technology we have licensed previously.”

To view the full press releases, visit https://ibn.fm/XQsLz and https://ibn.fm/lOqaT

About Genprex Inc.

Genprex is a clinical-stage gene therapy company focused on developing life-changing treatments for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new therapies for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. Genprex’s oncology program utilizes its proprietary, non-viral ONCOPREX(R) Nanoparticle Delivery System, which the company believes is the first systemic gene therapy delivery platform used for cancer in humans. ONCOPREX encapsulates the gene-expressing plasmids using lipid nanoparticles. The resultant product is administered intravenously, where it is then taken up by tumor cells that express tumor suppressor proteins that are deficient in the body. The company’s lead product candidate, REQORSA(TM) (quaratusugene ozeplasmid), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”) (with each of these clinical programs receiving a Fast Track Designation from the Food and Drug Administration) and for small cell lung cancer. Genprex’s diabetes gene therapy approach is comprised of a novel infusion process that uses an endoscope and an adeno-associated virus (“AAV”) vector to deliver Pdx1 and MafA genes directly to the pancreas. In models of type 1 diabetes, the genes express proteins that transform alpha cells in the pancreas into functional beta-like cells, which can produce insulin but are distinct enough from beta cells to evade the body’s immune system. In type 2 diabetes, where autoimmunity is not at play, it is believed that exhausted beta cells are also rejuvenated and replenished. For more information, visit the company’s website at www.Genprex.com.

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Zauben, known for its Model Z living wall concept, attended the 5th Annual Sustainability Private Capital Event on December 7-8, 2022. The event was jointly hosted by Sustain SoCal and Roth Capital Partners. Venture capitalists and investors from private equity, family offices, endowments, foundations and angels attended the conference. This two-day virtual event offered a mammoth networking and business opportunity to connect with C-level executives with established private sustainability companies, mostly series A/B, in the solar/storage, e-mobility, Smart City, circular economy and water verticals. 

Winner of several prestigious awards for sustainability and innovation, Zuben’s premier product, Model Z living wall, allows businesses, organizations, and anyone to bring the beauty and benefits of outdoor greenery indoors, without worrying about maintenance. Their system incorporates…

Read More>>

To learn more about the conference, please visit https://ibn.fm/0AUAF & https://ibn.fm/YBuOk.
To learn more about Zauben, please visit (https://www.zauben.com/).

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Canada Nickel (TSX.V: CNC) (OTCQX: CNIKF) has appointed two financial advisors: Deutsche Bank Securities Inc. and Scotiabank. The two banks will serve as financial advisors for the equity component of the project financing for CNIKF’s Crawford Nickel Sulphide Project. According to the announcement, Canada Nickel has been “engaged in discussions” for the past 18 months as it has worked to identify financial advisors. The feasibility study on the Sulphide Project is nearing completion, and the company’s next priorities are project financing and permitting activities to ensure that financing is in place in a timely manner. Deutsche Bank and Scotiabank will provide invaluable assistance in this process, including the evaluation of strategic and financial alternatives for the equity portion of the project financing as well defense advisory and planning. Canada Nickel noted that it is also working on engaging an advisor for the debt portion of the project financing in early 2023. “As we move into the next phase of advancing Crawford towards production, we are pleased to engage two of the world’s leading investment banks with a broad base of mining and industrial expertise, Scotiabank and Deutsche Bank, to advise the Company on alternatives for the equity portion of the project financing for Crawford,” said Canada Nickel chair and CEO Mark Selby in the press release. “We are also pleased to announce that our team has completed another significant permitting milestone on the critical path towards production, by filing the detailed project description with the Impact Assessment Agency of Canada earlier this week. We continue to target receipt of permits by mid-2025 with construction to immediately follow.”

To view the full release, visit https://ibn.fm/4MEmC

About Canada Nickel Company

Canada Nickel is advancing the next generation of nickel-sulphide projects to deliver nickel required to feed the high-growth electric vehicle and stainless steel markets. Canada Nickel has applied in multiple jurisdictions to trademark the terms NetZero Nickel(TM), NetZero Cobalt(TM) and NetZero Iron(TM), and is also pursuing the development of processes to allow the production of net zero carbon nickel, cobalt and iron products. The company provides investors with leverage to nickel in low political risk jurisdictions. Canada Nickel is currently anchored by its 100% owned flagship Crawford Nickel-Cobalt Sulphide Project in the heart of the prolific Timmins-Cochrane mining camp. For more information about the company, visit www.CanadaNickel.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing innovative treatments for patients suffering from dentofacial abnormalities and/or mild to moderate obstructive sleep apnea (OSA) and snoring in adults, announced a new strategic medical billing partnership with Nexus Dental Systems. According to the announcement, Vivos anticipates that the partnership will generate new revenue immediately and will enable the two companies, which currently operate independent billing platforms, to create one of the most comprehensive medical billing services in the dental industry. The new alliance will offer greater access to both in or out-of-network billing with all major medical insurance companies as well as facilitate enhanced case acceptances and insurance billing procedures and reimbursement. “For a long time, medical billing has been a barrier to wide acceptance of dental offices treating breathing and sleep disorders, which is why we have historically offered fee-based out-of-network claims assistance to Vivos providers and their patients,” said Vivos Therapeutics chair and CEO Kirk Huntsman in the press release. “Our Billing Intelligence Service currently achieves a 98% success rate for reimbursement on out-of-network oral appliance claims, which is extremely high. This new relationship will now give Vivos-trained dentists immediate access to some of the highest in-network reimbursement rates in the industry, allowing higher case acceptance for Vivos-trained providers. We believe this will create immediate additional revenue opportunities, not only for Vivos but for providers within each network, while patients pay less out-of-pocket expenses.”

To view the full press release, visit https://ibn.fm/2jaoh

About Vivos Therapeutics Inc.

Vivos Therapeutics is a medical technology company focused on developing and commercializing innovative diagnostic and treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities such as mild-to-moderate obstructive sleep apnea (“OSA”) as well as snoring in adults. The Vivos Method represents the first clinically effective, nonsurgical, noninvasive, nonpharmaceutical and cost-effective solution. It has proven effective in the treatment of an estimated 31,000 patients worldwide by more than 1,650 trained dentists. The Vivos Method includes the Vivos Complete Airway Repositioning and/or Expansion (“CARE”) appliance therapy and associated protocols that alter the size, shape and position of the soft tissues that comprise a patient’s upper airway and palate. The Vivos Method opens airway space and may significantly reduce symptoms and conditions associated with mild to moderate OSA, such as lowering Apnea Hypopnea Index scores. Vivos also markets and distributes SleepImage diagnostic technology under its VivoScore program for home sleep testing in adults and children. The Vivos Integrated Practice (“VIP”) program offers dentist training and other value-added services in connection with using the Vivos Method. For more information about this company, visit www.VivosLife.com.  

NOTE TO INVESTORS: The latest news and updates relating to VVOS are available in the company’s newsroom at http://ibn.fm/VVOS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Event agenda for kick-off event included special announcements, new releases, trainings, giveaways and more
• Hapi Travel is a membership-based travel club designed for maximum savings on the most luxurious vacation getaways throughout the world
• Post-COVID, people are ready to experience new locations and revisit places they love

The inaugural event for Hapi Travel Destinations recently wrapped up in Dallas, introducing the traveling world to a whole new approach to travel savings as well as a unique opportunity for those looking for additional income in the gig economy. A wholly owned subsidiary of Sharing Services Global (OTCQB: SHRG), Hapi Travel Destinations is a global leader in fun-filled, one-of-a-kind travel and offers exclusive travel-club membership.

The first-ever national travel event for Hapi Travel took place Nov. 11–12, 2022, and was designed to launch Hapi Travel. The event agenda included special announcements, new releases, trainings…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SHRG are available in the company’s newsroom at http://ibn.fm/SHRG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

• Brian Haugli, with extensive experience in the field of cybersecurity, having led key programs for the Department of Defense, the Pentagon, and Fortune 500 companies, discusses the growing cybersecurity needs of small business, and the new technologies that now make such security far more accessible and affordable
• SMBs face, on average, 11 cyberthreats a day, with over 70% of SMBs facing cyberattacks, and 60% being put of business within six months after an attack
• SideChannel vCISOs (Virtual Chief Information Security Officers) make the highest quality cybersecurity expertise available for significantly less than the cost of a full-time CISO, representing 400-plus years of experience in cybersecurity and a bespoke cybersecurity program perfectly sized for growing enterprises

The cybersecurity market revenue is projected to reach over $156 billion in 2022, driven by the increased need for solutions that protect companies from threats of malware, ransomware, and vulnerabilities that let malicious characters infiltrate critical systems. This revenue is expected to grow at a CAGR of 10.92%, resulting in a value of over $262 billion by 2027 (https://ibn.fm/wE6KB). On the Cloud Security Reinvented with Andy Ellis podcast (https://ibn.fm/KV6vv), Ellis talks with Brian Haugli, managing partner and CEO at SideChannel (OTCQB: SDCH). In the episode titled “How to Let Go of the ‘Gotcha’ Mentality in Security with Brian Haugli,”  Haugli and Ellis discuss the necessity for cybersecurity and how small-to-mid-market companies are in need of solutions to accommodate the increased threats to technological systems.

According to Haugli, there are hundreds of thousands of companies, outside the Fortune 2000, that require diligence on what their security program looks like, and the question is always who can lead such an assessment and whether they can afford it. “The market is actually very hot when it comes to…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Amesite (NASDAQ: AMST) is a leading artificial intelligence software company offering a cloud-based learning platform for business and education markets. The company today announced that it has submitted a response to the National Institute of Standards and Technology’s (“NIST”) request for information (“RFI”) regarding the design of potential semiconductor and microelectronics innovation manufacturing institutes in the United States. The Creating Helpful Incentives to Produce Semiconductors (“CHIPS”) for America Act is set to offer an array of supportive funding mechanisms to transform the U.S. semiconductor industry. On the heels of a recent collaboration with NAFEO, Amesite stands ready to help fulfil the talent shortages and diversity challenges the semiconductor industry faces today. “Amesite and NAFEO have the ability to launch sophisticated technological programs in as little as 24 hours around the globe, and are targeting funding for HBCUs and PBIs, to improve the diversity of the semiconductor workforce,” said Amesite CEO and Founder, Dr. Ann Marie Sastry. “The U.S. semiconductor urgently needs to upskill and reach diverse talent – and the best way to do that is to leverage a proven SaaS partnership. We are grateful for the opportunity to comment and are eager to help the U.S. lead in this space.”

To view the full press release, visit https://ibn.fm/xb1Xi

About Amesite Inc.

Amesite delivers its scalable, customizable, white-labeled online learning platform to universities, businesses, museums, and government agencies, enabling them to deliver outstanding digital learning. Amesite provides a single system that combines eCommerce, instruction, engagement, analytics, and administration using best-in-class infrastructure to serve multibillion-dollar online learning markets. For more information, visit https://amesite.com.

NOTE TO INVESTORS: The latest news and updates relating to AMST are available in the company’s newsroom at https://ibn.fm/AMST

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Zeeve, a leading web3 infrastructure automation platforms and node-as-a-service provider, is partnering with DigitalOcean to expand its cloud network. Zeeve has added platform-wide support for DigitalOcean, providing users with an even more seamless experience across public and private blockchain protocols. According to the announcement, the partnership will enable users to choose from an array of cloud platforms that are integrated on Zeeve. The company noted that the integration will benefit more than 15,000 developers as well as high-growth startups and other businesses using Zeeve’s platform; the larger web3 ecosystem will also benefit by gaining access to full, archive and validator nodes in minutes through Zeeve Managed Cloud, which is offered by major cloud providers including DigitalOcean, or by configuring their own DigitalOcean cloud account for hosting nodes. The world’s leading cloud platform, DigitalOcean is popular among developers because of its great workflow, dependable network, dynamic provisioning capabilities and affordability. “Our focus at Zeeve is to provide as much flexibility as possible to our users when it comes to the choice of cloud infrastructure to deploy their nodes and networks,” said Zeeve cofounder and CEO Dr. Ravi Chamria in the press release. “DigitalOcean is simple, affordable and offers high-performing compute with predictable pricing, which makes it suitable for startups, and small- to medium-size businesses operating in the web3 space. We have integrated DigitalOcean along with other leading cloud players with Zeeve to offer the most optimized web3 stack where developers can not only deploy nodes on their own DigitalOcean accounts but can also opt for fully managed service from Zeeve.”

To view the full release, visit https://ibn.fm/6UMku

About Zeeve

Zeeve is the leading blockchain Infrastructure as a service platform helping enterprises and blockchain startups build, deploy and manage reliable decentralized apps, blockchain nodes, and networks. Zeeve is a low-code automation platform that is cloud agnostic and supports multiple blockchain protocols with advanced analytics and monitoring of nodes and networks. Zeeve features a powerful set of APIs to build dApps for a plethora of use cases across industries. For more information about the company, please visit www.Zeeve.io.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Nextech (CSE: NTAR) (OTCQB: NEXCF) (FSE: EP2) today announced that it has determined to pursue a direct spinout of its Toggle3D design studio SaaS software platform through a wholly owned subsidiary of the company (“Subco”). It is currently anticipated that the transaction will proceed by way of plan of arrangement pursuant to which the Toggle3D and associated assets will be spun out into a new Subco, subject to final tax and legal structuring considerations. “The spinout of ARway on October 26th has proven to be a tremendously successful way to unlock value for Nextech shareholders. Now we are announcing that we are going to do the same thing with Toggle 3D,” said Evan Gappelberg, CEO of Nextech. “We believe there is a tremendous amount of value currently trapped inside Nextech and these spinouts are aimed at unlocking that value by listing pure play technology companies. We believe that Toggle 3D is now commercially ready with a laser focused team and will be well received by the market. Creating value for Nextech shareholders of which I am the single largest with 10.7mill shares has always been a major focus of mine. This Toggle3D spinout and the possibility of additional future spinouts are intended to unlock the value of the technology that we have been heavily investing in, incubating and building inside Nextech for the last 4-years.”

To view the full press release, visit https://ibn.fm/43r0I

About Nextech AR Solutions Corp.

Nextech is the engine accelerating the growth of the metaverse. Using breakthrough AI, Nextech AR is able to quickly, easily and affordably ARitize (transform) vast quantities and varieties of existing assets at scale making products, people and places ready for interactive 3D use, giving creators at every level all the essential tools they need to build out their digital AR vision in the metaverse. The company’s platform-agnostic tools allow brands, educators, students, manufacturers, creators, and technologists to create immersive, interactive and the most photo-realistic 3D assets and digital environments, compose AR experiences, and publish them omnichannel. With a full suite of end-to-end AR solutions in 3D commerce, education, events, and industrial manufacturing, Nextech AR is in a unique position to meet the needs of the world’s biggest brands and all metaverse contributors. For more information about the company, visit www.NextechAR.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Data443 (OTC: ATDS), a data security and privacy software company, today announced that it has partnered with IBN, a multifaceted financial news and publishing company for private and public entities, to provide corporate communications expertise. Data443 is committed to organizing the world’s information by identifying and protecting sensitive data. The company provides software and services to secure information across devices and databases both at rest and in-transit, locally, on a network or in the cloud. As part of the client partner relationship, IBN will leverage its investor based distribution network of 5,000+ key syndication outlets, various newsletters, social media channels, wire services via InvestorWire, blogs and other outreach tools to generate greater awareness for Data443. “Data security is a fast-growing area within IT, with analysts forecasting sector growth from roughly $19 billion in 2021 to $54.23 billion by 2027. For Data443, that represents a significant opportunity,” said Chris Johnson, director of client solutions for IBN. “We’re excited to customize our comprehensive suite of corporate communications solutions for Data443 as it leverages a privacy-forward methodology and diverse product offerings to address the evolving data security needs of its growing client base.”

To view the full press release, visit https://ibn.fm/FnyKU

About Data443 Risk Mitigation Inc.

Data443 provides data security and privacy management solutions in homes, offices and across enterprises for the multi-cloud. Trusted by over 10,000 business customers, Data443 organizes the world’s data by identifying and protecting sensitive data in various locations, platforms and formats. For more information, visit the company’s website at www.Data443.com.

NOTE TO INVESTORS: The latest news and updates relating to ATDS are available in the company’s newsroom at https://ibn.fm/ATDS

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

FE Battery Metals (CSE: FE) (OTCQB: FEMFD) today announced its receipt of an update from SGS metallurgical laboratory, located in Lakefield, Ontario, regarding progress for the ongoing metallurgical testwork on the Augustus Lithium Property. According to the update, the testwork successfully produced a spodumene concentrate with 6.08% lithium oxide (“Li2O”) for the composite samples from the Augustus Property. In addition, the company announced it has closed a non-brokered private placement of 3,707,500 flow-through (“FT”) shares for gross proceeds of $ 2,225,475 by issuing a total of 2,040,000 Quebec FT shares, each at price of $0.625, and 1,667,500 National FT shares, each at a price of $ 0.57. In connection with the private placement, finder’s fees may be paid to eligible parties in accordance with CSE policies. Closing of the proposed private placement is subject to obtaining all required regulatory approvals, including from the CSE.

To view the full press release, visit https://ibn.fm/iCpvv

About FE Battery Metals Corp

FE Battery Metals is focused on identifying, exploring and advancing early-stage lithium pegmatite projects in Canada. The company’s primary efforts have been on exploration projects located in Quebec, with its flagship property being the Augustus Lithium Property. Augustus is located in the immediate vicinity of Val d’Or, Quebec, where several historical prospects and a previously active lithium mine is located within a 10km radius from the property. North American Lithium mine (“NAL”) and Authier are two notable projects in the area that highlight the potential of the Augustus Lithium Property.

NOTE TO INVESTORS: The latest news and updates relating to FEMFD are available in the company’s newsroom at https://ibn.fm/FEMFD

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Processa Pharmaceuticals (NASDAQ: PCSA), a diversified clinical-stage company developing products to improve survival and/or the quality of life for patients with unmet medical need conditions, today announced positive top-line results on the clinical symptoms associated with gastroparesis from a 4-week Phase 2A study of PCS12852. The randomized, dose-response study for the treatment of patients with gastroparesis is designed to evaluate the safety, efficacy and pharmacokinetics of two dosage regimens of PCS12852 versus placebo. “This Phase 2A gastroparesis study shows a trend toward an increase in the gastric emptying rate and clinically meaningful improvements in gastroparesis symptoms in patients receiving a 0.5 mg daily dose of PCS12852,” said Dr. Sian Bigora, chief development officer at Processa. “The reduction in clinical symptoms and the continued improvement in the total ANMS GCSI-DD score and multiple individual symptom scores were better for the PCS12852 0.5 mg daily dose group than placebo or the 0.1 mg group. These findings suggest that a longer treatment than 28 days may result in greater differences in the gastroparesis symptoms for the 0.5 mg PCS12852 daily dose group when compared to the placebo dose group. These results, consistent with the previous pre-clinical and clinical studies, give us confidence that dosing 0.5 mg of PCS12852 daily for at least 12 weeks should improve the clinical symptom score more than a placebo treatment.”

To view the full press release, visit https://ibn.fm/pwLEu

About Processa Pharmaceuticals Inc.

The mission of Processa is to develop products with existing clinical evidence of efficacy for patients with unmet or underserved medical conditions who need treatment options that improve survival and/or quality of life. The company uses these criteria for selection to further develop its pipeline programs to achieve high-value milestones effectively and efficiently. Active clinical pipeline programs include Next Generation Capecitabine PCS6422 (metastatic colorectal cancer and breast cancer), PCS499 (ulcerative necrobiosis lipoidica) and PCS12852 (GI motility/gastroparesis). For more information, visit the company’s website at www.ProcessaPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to PCSA are available in the company’s newsroom at https://ibn.fm/PCSA

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Grom (NASDAQ: GROM), a media, technology and entertainment company dedicated to family friendly programming, web filtering technology and safe social media for kids, has closed its previously announced underwritten public offering of 1,415,682 units at a price to the public of $2.89 per unit and 314,422 pre-funded units at a price to the public of $2.889 per pre-funded unit. Grom secured aggregate gross proceeds of approximately $5.0 million, prior to deducting underwriting discounts, commissions, and other estimated offering expenses. In addition, the company granted the underwriters a 45-day option to purchase up to an additional 259,515 units or pre-funded units solely to cover over-allotments, if any, less underwriting discounts and commissions. On Dec. 12, 2022, the underwriters exercised the option to purchase an additional 495,602 warrants. The company intends to use the net proceeds for general corporate purposes, which may include marketing and advertising, acquisitions and strategic partnerships, research and development of original content and technology, expansion of its intellectual property portfolio by investment, and other working capital and general corporate purposes. EF Hutton Acquisition Corp. (NASDAQ: EFHTU), division of Benchmark Investments LLC, acted as sole book running manager for the offering.

To view the full press release, visit https://ibn.fm/lDz21

About Grom Social Enterprises Inc.

Grom is a growing social media platform and original content provider of entertainment for children under 13 years of age, which provides safe and secure digital environments for kids that can be monitored by their parents or guardians. The company has several operating subsidiaries, including Grom Social, which delivers its content through mobile and desktop environments (web portal and apps) that entertain children, let them interact with friends, access relevant news, and play proprietary games while teaching them about being good digital citizens. The company owns and operates Top Draw Animation, which produces award-winning animation content for some of the largest international media companies in the world. The company owns an 80% stake in Curiosity Ink Media, which is a global media company that develops, acquires, builds, grows and maximizes the short, mid and long-term commercial potential of Kids & Family entertainment properties and associated business opportunities. Grom also includes Grom Educational Services, which has provided web filtering services for K-12 schools, government and private businesses. For more information, please visit the company’s website at https://gromsocial.com or for investor relations information, please visit https://investors.gromsocial.com.

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Cerberus Cyber Sentinel (NASDAQ: CISO), a managed compliance and cybersecurity provider, was spotlighted during a recent Smart Money Circle (“SMC”) episode. During the segment, host Adam Sarhan interviewed David Jemmett, CISO CEO and an expert in cybersecurity, healthcare, compliance and governmental regulations. According to SMC, Jemmett has been intimately involved in designing, building, revamping, and/or managing networks and data centers worldwide. During the interview, Jemmett talked about his 35-year career, which included executive management and technology experience with telecommunications, managed services and cybersecurity consulting services — ultimately leading to him creating Cerberus Cyber Sentinel. Jemmett explained that he started the company as a result of previous clients coming to him, seeking help and advice in a world that was becoming increasingly plagued by cybersecurity issues. “Someone is being hacked every 11 seconds,” said Cerberus Cyber Sentinel CEO David Jemmett during the interview. “Before it was a black box and people were like, it will never happen to me. It’s not a matter of if anymore, it’s a matter of when. I mean, 35% of the traffic on the internet is bots looking for, you know, a penetration point. They’re looking to insert something so they can get into your data. [And] it’s just like the pandemic, if you get infected, you can’t tell right away, and you might infect somebody else  before they figure out you’re sick. And that’s the problem with cyber, is people can’t physically see it and can’t identify it. But it’s like the pandemic, and it spreads very, very quickly.”

To view the full interview, visit https://ibn.fm/0Lg6g

About Cerberus Cyber Sentinel Corp.

Cerberus Sentinel is an industry leader in managed cybersecurity and compliance provider. The company is rapidly expanding by acquiring world-class cybersecurity, secured managed services and compliance companies with top-tier talent that utilize the latest technology to create innovative solutions to protect the most demanding businesses and government organizations against continuing and emerging security threats and compliance obligations. For more information about the company, visit www.CerberUSSentinel.com.

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on Newsy Morning Rush to discuss the testimony by Twitter whistleblower Peiter Zatko regarding the company’s data and cybersecurity troubles — and what other U.S. companies and even Twitter users can learn from the company’s experience. During the interview, Haugli called the Twitter situation “troublesome,” as he pointed out the fact that Twitter leadership ignored the concerns that Zatko raised. “Cybersecurity is not an IT risk, it’s an operational risk that really needs to be addressed as an enterprise,” said SideChannel CEO Brian Haugli during the interview. “That means that the CEO, the CFO, even the board, need to take it seriously. They need to be looking at it. Believe it or not, a lot of organizations aren’t at that maturity level, but I would have expected Twitter to have been at that point in their security program to be listening to their chief information security officer, who’s raising risks to them, and then taking action and supporting from the top down how to actually address the deficiencies and gaps that he’s highlighting. . . . We definitely need to have a level of regulation that is both enforceable and taken seriously by the organizations that it’s put on; the government also actually needs to be able to enforce it.”

To view the full interview, visit https://ibn.fm/KglrF

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Jupiter Wellness (NASDAQ: JUPW), a wellness company focused on hair, skin and sexual wellness, has been approved to dual list its shares on Upstream beginning Jan. 10, 2023; the ticker symbol will remain JUPW. A revolutionary trading app for digital securities and NFTs, Upstream is powered by Horizon Fintex and MERJ Exchange Limited. The company is inviting global investors to create an account on Upstream and complete a simple KYC identity verification in order to prepare for trading; the Upstream market is open Monday through Friday, 1 a.m. to 9 p.m. EST. According to the announcement, Jupiter anticipates that the dual listing will provide the company with access to a global, digital-first investor base that trades using an array of methods, including USDC digital currency, credit, debit, PayPal and USD; this broader access will unlock liquidity and enhance price discovery while globalizing the opportunity for investors to invest in Jupiter. “Building shareholder value is an ongoing goal of ours,” said Jupiter Wellness CEO Brian John in the press release. “We believe a dual listing on Upstream will expand the ways we reach potential supporters and give us access to innovative new ways to introduce the company to potential shareholders and customers.”

To view the full press release, visit https://ibn.fm/RIFiT

About Jupiter Wellness Inc.

Jupiter Wellness is a diversified company that supports health and wellness by researching and developing over-the-counter (“OTC”) products and intellectual property. The company’s product pipeline addresses a range of conditions, including hair loss, eczema, burns and sexual wellness. Revenue is generated through the sales of OTC and consumer products, contract research agreements, and licensing royalties. For additional information about this company, please visit www.JupiterWellnessInc.com.

NOTE TO INVESTORS: The latest news and updates relating to JUPW are available in the company’s newsroom at https://ibn.fm/JUPW

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, has filed its audited financial statements and is reporting on corporate highlights for the fiscal year ending Aug. 31, 2022. Highlights include the World Intellectual Property Organization publishing TRYPF’s international PCT patent application, which covers the intravenous administration of psilocybin and psilocin. The patent is connected to Tryp’s development of TRP-8803, an intravenous infusion of psilocin designed to significantly reduce the time to onset of the psychedelic state, control the depth and duration of the psychedelic experience, and reduce the overall duration of the intervention to a commercially feasible timeframe. Other highlights include the filing of provisional patents for the use of psilocybin for the treatment of patients with binge eating disorder and for the treatment of patients with fibromyalgia. The report also noted the filing of a provisional patent for crystalline forms of TRP-8803. In addition, Tryp started preparations for a phase 2a trial using TRP-8802 to evaluate psilocybin-assisted therapy among patients with fibromyalgia. “Tryp has continued to execute its multipronged strategy of exploring the clinical utility of psilocybin-assisted psychotherapy, expanding its IP portfolio, and advancing TRP-8803 (IV-infused psilocin), the company’s proprietary and eventual commercial product,” said Tryp Therapeutics CEO Jim Gilligan in the press release. “To that end, Tryp expects to have the interim results from our phase 2a clinical binge eating disorder trial as early as January 2023 and has submitted several provisional patents related to fibromyalgia, binge eating disorder, and co-formers of TRP-8803. Furthermore, the company has completed a series of pharmacology and toxicology programs necessary to advance TRP-8803 into the clinic. With a burgeoning pipeline and a variety of novel and impactful provisional patents in place, we look forward to continuing to execute our business plan in 2023 and beyond.”

To view the full release, visit https://ibn.fm/rqUez

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• Cost-cutting becomes a priority for businesses looking to remain strong during record inflation
• “It’s always a question of what to prioritize and which costs to minimize while preserving the quality of your product,” states a Forbes article
• Cerberus ensures that companies not only stay more secure but also build a culture of cybersecurity

In a fragile economy with a possible recession looming on the horizon, savvy companies are taking a close look at ways to tighten their belts. As they do so, a recent Forbes article cautions wise business leaders to keep cybersecurity in the forefront (https://ibn.fm/ui99g), a strategy that Cerberus Cyber Sentinel (NASDAQ: CISO) can help with.

The article details “why cyber protection should become a ‘must-have,’ not a ‘nice-to-have’ in your business decision-making process and why you should prioritize it in times of economic uncertainty.” Titled “Why Businesses Shouldn’t Cut Cybersecurity Costs—Especially During a Crisis,” the…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to CISO are available in the company’s newsroom at https://ibn.fm/CISO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Pressure BioSciences (OTCQB: PBIO), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and specialty process development and production services to the worldwide nutraceuticals, cosmetics, biotherapeutics and food/beverage industries, has shipped its first-ever commercial production lot of an UltraShear nanoemulsion product. The revolutionary product was created and enabled by PBIO’s Ultra Shear Technology(TM) nanoemulsification platform. According to the announcement, the product, which was designed for Safer Medical of Montana (“SMM”), is a CBD oral spray. Earlier this year, PBIO and SMM entered into a multiyear agreement that covers three phases of development and commercialization of a custom-formulated oral spray of hemp-derived nanoemulsified CBD designed for rapid absorption and effectiveness. “This launches a new chapter for Pressure BioSciences, as UltraShear commercialization enters into a phase of scale up and rapid growth,” said Pressure BioSciences director of sales and marketing John B. Hollister in the press release. “PBI has long established itself as an expert in the development and application of extreme high-pressure technology to enable remarkable and important new scientific and production capabilities, but UltraShear now opens an extraordinarily broad range of important and large new commercial application markets, from pharmaceuticals to nutraceuticals, cosmetics, food and beverages, agrochemicals and many more. Black Ops Nano CBD is the first UltraShear product, but vastly more products, far beyond this initial cannabinoid opportunity, will quickly follow.”

To view the full press release, visit https://ibn.fm/gIEc7

About Pressure BioSciences Inc.

Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. PBIO’s products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or “PCT”) hydrostatic pressure. PCT is a patented-enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of PBIO’s pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the bio-pharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit the company website at www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/PBIO

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Field Trip Health (OTC: FTHWF) (TSX.V: FTHW), a leading standalone psychedelic-assisted therapy business with clinical operations and research facilities in multiple countries, is focused on delivering innovative services to drive the best therapeutic outcomes with one of the most experienced clinical teams in the industry. Through its technology-empowered clinics and apps that are designed to scale globally, the company helps people through an integrated, evidence- based approach to healing and thriving. For more information, visit the company’s websites at https://www.meetfieldtrip.com, https://www.fieldtriphealth.com and https://www.fieldtriphealth.nl.

To join the KCSA Mental Health Investor Conference, visit https://ibn.fm/KCSA2022MentalHealthQ4

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

Filament Health (OTCQB: FLHLF) (NEO: FH) is a clinical-stage natural psychedelic drug development company. The company believes that safe, standardized, naturally derived psychedelic medicines can improve the lives of many, and its mission is to see them in the hands of everyone who needs them as soon as possible. Filament’s platform of proprietary intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The company is paving the way with the first-ever natural psychedelic drug candidates. For more information, visit the company’s website at www.filament.health or contact [email protected].

To join the KCSA Mental Health Investor Conference, visit https://ibn.fm/KCSA2022MentalHealthQ4

About InvestorBrandNetwork’s Virtual Coverage

The InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company, provides the online investment community with custom-built portals that include summaries on hundreds of presenting companies. In addition to enabling proficient evaluation of each company via one-click access to market research tools and helpful website links, IBN utilizes social media and syndicated articles to maximize the visibility of various investor conferences.

For more than a decade, IBN has provided real-time coverage for numerous global events and conferences through its various brands, social media accounts and investment newsletters. To further expand visibility of participating companies at these events, and to ensure another successful year for its event collaborations, IBN’s syndication partners have extended digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

InvestorBrandNetwork (IBN)
Los Angeles, California
www.InvestorBrandNetwork.com
310.299.1717 Office
[email protected]

DSG Global’s (OTCQB: DSGT) wholly owned subsidiary, Vantage Tag Systems, has announced the debut of the V-Club GPS Fleet Management-enabled Fleet Cart at the PGA Merchandise Show in Orlando, Florida, on Jan 24-27, 2023. Designed as a direct alternative to incumbent fleet selections, the V-Club sets new standards for performance, golfer comfort/safety, and affordability. To celebrate the debut, Vantage Tag Systems is giving away two of the new fully outfitted V-Club Luxury fleet golf carts at the PGA show from booth #3433. “I’ve been in this business for over 25 years.” said DSGT CEO Bob Silzer. “With very few changes to the present fleet car, the all-new Vantage V-Club fleet cart is the most complete offering in the industry at a price point that is a new benchmark for golf operators who are looking to enhance their fleet management capabilities, appearance and golfer experience.”

To view the full press release, visit https://ibn.fm/iyfOu

About DSG Global Inc.

DSG Global is an emerging global technology company with an array of interconnecting businesses in some of the fastest-growing market sectors. DSGT has roots in the golf industry, in which it specializes in fleet management with patented analytics, mobile touch screen engagement and electric golf carts under the Vantage Tag Systems (“VTS”) brand.

NOTE TO INVESTORS: The latest news and updates relating to DSGT are available in the company’s newsroom at https://ibn.fm/DSGT

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and the Clean Beverage(R) company, today announced that it has added two new direct-store-delivery (“DSD”) partners, C&M Sales and Alber & Leff Foods Company, to cover the entire state of Arkansas and Western Pennsylvania, respectively. With the expansion, Alkaline88(R) has DSD coverage in fourteen states as it continues to grow sales in the convenience and grocery channels. “The addition of two great new DSD partners will help Alkaline88 continue to grow in important regional grocery chains as well as earn shelf space in more of the 150,000 convenience stores in the country,” said Frank Lazaran, president and CEO of The Alkaline Water Company. “In the past year, Alklaine88 has become a top-15 value-added water brand in the convenience channel. According to Nielsen data for the 52 weeks ending Nov. 8, 2022, Alkaline88’s year-over-year sales growth rate in c-stores was nearly 11 times greater than that of the overall category and was the strongest of the other top-30 brands.”

To view the full press release, visit https://ibn.fm/zBUR5

About The Alkaline Water Company

The Alkaline Water Company is the Clean Beverage(R) company making a difference in the water you drink and the world we share. Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for Alkaline88. To purchase The Alkaline Water Company’s products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

SideChannel Inc. (OTCQB: SDCH) CEO Brian Haugli was a guest on “Mornings with Maria,” a Fox Business program that features industry titans and economic experts discussing the major news and themes driving the business day and the market moves. Haugli discussed rising concerns that TikTok, an application owned by China-based DanceByte, presents a national security issue. Those concerns have been fueled by GOP leaders calling for the application to be banned and the FBI issuing a statement about the possibility that the Chinese government could use the app to control data collection on millions of users, control the recommendation algorithm or control software on millions of devices. “[TikTok] is an application that runs on your phone, widely popular, but this application has access to things on your phone that you might hold dear,” said SideChannel CEO Brian Haugli during the interview. “Your contacts, your locations, your buying intent, your shopping history, your browser history — everything that you probably want to keep private. That application has access to your phone in a way that could give them access to all of that information. Why it would be considered a national security threat, in my opinion, is that you’re now able to build a profile on every individual who is using that application. You’re able to take that information in aggregate, and in the hands of a foreign national, a foreign party, what could be done, right? . . . We have the opportunity to put pressure on Google and Apple to remove this application from the store. We have the opportunity to build better regulations within the United States and can actually set up infrastructure that could block access to this data or this data leaving our environment. It’s not something that the U.S. has set up today, and it’s something that I think we very much need.”

A provider of cybersecurity services and technology for emerging and middle-market companies, SideChannel also announced that it is partnering with InvestorBrandNetwork (“IBN”) for its corporate communications. IBN is a multifaceted financial news and publishing company for private and public entities. The agreement calls for IBN to leverage its investor-based distribution network of more than 5,000 syndication outlets along with multiple newsletters, social media channels, wire services and blogs to generate greater awareness for SideChannel.

To view the full interview, visit https://ibn.fm/wno68

To view the full press release, visit https://ibn.fm/i8dH4

About SideChannel Inc.

SideChannel is committed to creating top-tier cybersecurity programs for mid-market companies to help them protect their assets. SideChannel employs what it believes to be skilled and experienced talent to harden these companies’ defenses against cybercrime, in its many forms. SideChannel’s team of C-suite level information security officers possess a combined experience of more than 400 years in the industry. To date, SideChannel has created more than 50 multilayered cybersecurity programs for its clients. For more information about the company, please visit www.SideChannel.com. 

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, today announced the appointment of Marc Malandro, Ph.D., to the company’s scientific advisory board. Dr. Malandro, a highly regarded scientific leader and expert in genomics, molecular biology, biochemistry and bioengineering, will serve alongside other key thought leaders in their respective fields to guide the company’s initiatives and growth strategy. “Marc is not only a very insightful scientist, but he is an equally perceptive and thoughtful innovator. His understanding of the business of science, and the commercial application of novel discovery, is precisely why he is such a valuable scientific advisor,” said Predictive Oncology’s CEO and Board Chairman Raymond F. Vennare. “Marc’s understanding of the depth and breadth of the biopharmaceutical industry is invaluable as we look to build relationships and progress to help accelerate drug discovery and advance drug development.”

To view the full press release, visit https://ibn.fm/Jje9E

About Predictive Oncology Inc.

Predictive Oncology is a knowledge-driven company focused on applying artificial intelligence (“AI”) to develop optimal cancer therapies, which can lead to more effective treatments and improved patient outcomes. Through AI, Predictive Oncology uses a biobank of 150,000+ cancer tumors, categorized by patient type, against drug compounds to help the drug discovery process and increase the probability of success. The company offers a suite of solutions for oncology drug development from early discovery to clinical trials. For more information, visit the company’s website at www.Predictive-Oncology.com.

NOTE TO INVESTORS: The latest news and updates relating to POAI are available in the company’s newsroom at http://ibn.fm/POAI

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

• SideChannel is a company making cybersecurity accessible and simple, especially for small and mid-sized businesses (“SMBs”)
• The company provides cybersecurity services in the form of virtual CISOs (“vCISOs”), engineering services that enable the vCISOs to provide operational day-to-day security and privacy to clients, and proprietary security software called Enclave
• SideChannel’s differentiator from its competition is its team of experts, and recently the company hired IT and cybersecurity veteran Sean Higgins as Principal Consultant
• In this role, Sean will help client companies’ CISOs and senior management evaluate and have greater levels of confidence in their security programs

SideChannel (OTCQB: SDCH), a company focused on making cybersecurity more accessible and simple, especially for small and mid-sized businesses (“SMBs”), recently expanded its team with the hiring of Sean Higgins as Principal Consultant (https://ibn.fm/AeZGL).

An information technology (“IT”) veteran with over 35 years of experience, almost 30 of which have been focused on cybersecurity, Sean previously worked as the Chief Technology Officer (“CTO”) and Co-Founder at Herjavec Group, a global cybersecurity product and…

Read More>>

NOTE TO INVESTORS: The latest news and updates relating to SDCH are available in the company’s newsroom at https://ibn.fm/SDCH

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, will be presenting live at the VirtualInvestorConferences.com event; the conference is scheduled for Dec. 15, 2022. According to the announcement, Tryp Therapeutics CEO Jim Gilligan will present during the event. Gilligan’s presentation is slated to begin at 2 p.m. ET, and the presentation will include time set aside for a real-time Q&A session.  In addition, company officials will be available for one-on-one meetings with investors on Dec. 16 and Dec. 19–Dec. 20. An archived webcast of the presentation will be available after the event.

To view the full presentation, visit https://ibn.fm/9f503

To view the full release, visit https://ibn.fm/sMa8A

About Tryp Therapeutics Inc.

Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.

NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Mydecine (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology company engineering the next wave of innovative medications and treatment protocols to directly address addiction and mental health. The company today announced, further to its Sept. 1 news release, it has closed the sale of all of the issued and outstanding shares of its wholly owned subsidiary, Mindleap Health, to PanGenomic Health Inc., a company listed on the Canadian Stock Exchange (“CSE”). The sale is a significant step towards refocusing Mydecine’s resources on its primary strategy of discovering and developing innovative pharmaceutical psychedelic substances to meet the unmet needs of millions of patients worldwide. “We are extremely proud of what we built with the Mindleap App,” said Josh Bartch, chairman and CEO of Mydecine. “Mindleap fills a necessary void in mental health and gives users the tools they need to improve their overall health and wellbeing. The Mydecine team looks forward to watching the application flourish and grow and will provide support at every step of the way. We spoke with numerous parties when we made the decision to part ways with Mindleap, and ultimately, we decided the team at PanGenomic shared the same vision and had the team and the expertise to take the application to the next level.”

To view the full press release, visit https://ibn.fm/G5qfl

About Mydecine Innovations Group Inc.

Mydecine is a biotechnology company developing the next generation of innovative medications and therapies to address addiction and mental health. The core strategy blends advanced technology with an elaborate infrastructure for drug discovery and development. Mydecine’s dedicated multinational team constantly develops new paths for breakthrough treatment solutions in areas with considerable unmet needs. By collaborating with some of the world’s leading specialists, the company aspires to responsibly speed up the development of breakthrough medications to provide patients with safer and more effective treatment solutions. At the same time, Mydecine’s approach focuses on the next generation of psychedelic medicine by creating innovative compounds with unmatched therapeutic potential through its clinical trial efforts with world-class scientific and regulatory expertise. Founded in 2020, Mydecine is based out of Colorado, USA, with extended offices in Alberta, Canada, and Leiden, Netherlands. For more information about the company, please visit www.Mydecine.com.

NOTE TO INVESTORS: The latest news and updates relating to MYCOF are available in the company’s newsroom at https://ibn.fm/MYCOF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork

Ideanomics (NASDAQ: IDEX), a global company focused on accelerating the commercial adoption of electric vehicles (“EV”), today announced that its subsidiary Energica has begun selling its high-performance electric motorcycles in Japan and Australia. Per the announcement, the first batch of motorbikes will arrive in both countries in Q1 2023. “Japan is a key market for us. Energica’s presence in Japan was sealed in August at the eight-hour Suzuka Circuit where our bikes were acclaimed for their performance during the numerous test laps at this prestigious and world-renowned endurance race,” said Livia Cevolini, Energica Motor Company CEO. “Our partnership with Estar & Co. Ltd. in January 2020 has also improved our efforts in developing our Asia-Pacific network.”

To view the full press release, visit https://ibn.fm/CawRK

About Ideanomics Inc.

Ideanomics is a global group with a simple mission: accelerating the commercial adoption of electric vehicles. By bringing together vehicles, charging and financing solutions under one roof, Ideanomics is the one-stop partner needed to simplify the transition to and operation of any EV fleet. For more information about the company, visit www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.

As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork